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ABSTRACT
Rainey, Felynncia Renee. PhD. The University of Memphis. May/2012. Towards
Monitoring of the Anesthetic Drug Propofol: Design, Development, and Characterization
of an Automated Flow Analytical System. Major Professor: Ernő Lindner, PhD.
Propofol is an intravenous anesthetic drug commonly used for the maintenance of
sedation for critically ill patients in the ICU. Current standard dosing paradigms, which
use weight, age, and sex to determine dosage amounts, are not universal to all patients.
Consequently, some patients may be under-sedated, while others may be over-sedated.
Patient under-sedation can affect patient comfort, proper patient-ventilator
synchronization, and blood oxygenation. Patient over-sedation can result in the
development of Propofol Infusion Syndrome (PRIS). PRIS can cause many
physiological dysfunctions, even death, especially in children. To address this issue an
electrochemical propofol sensor and an automated flow analytical system (AFAS) have
been designed in our lab. The AFAS is aimed toward the feedback controlled monitoring
of propofol using microfabricated planar electrochemical sensors.
The AFAS is composed of a flow-through electrochemical cell, computer
controlled actuator, multi-position valve, peristaltic pump, and potentiostat. The system
allows the user to implement complex analytical tasks, including flow injection analysis,
continuous monitoring, and multipoint calibration with sample measurements.
Measurements can be performed under varied experimental conditions, including a wide
range of electrode configurations, sampling schemes, sample volumes, and sample
concentrations.
A membrane coated sensor for measurement of propofol has been developed. The
AFAS was used to characterize the response of the membrane coated electrode in
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repeated measurements, using ferrrocenemethanol as a model compound. The influence
of the thickness of the membrane on the measured electrochemical signal was also
examined.
Finally the AFAS was used to demonstrate the performance characteristics of a
membrane coated sensor for the measurement of propofol. The AFAS was also used to
determine the precision and accuracy of propofol measurement in the physiologically
relevant concentration range and the effect of interfering compounds on propofol
measurement.
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INTRODUCTION
In the field of analytical chemistry there is a constant quest to improve the

detection limit, the sensitivity and selectivity of the measurements, and to decrease the
needed sample/reagent volumes. There is also a drive to decrease analysis time without
unduly sacrificing measurement accuracy. Traditional chemical analysis is done using
batch methods (i.e., pipetting, titrating, etc.), and is also known as beaker chemistry. It
has been the standard method of analysis for the past 200 years. Batch methods are often
time consuming and labor intensive. Also, the errors associated with batch methods are
highly user-dependent.
With the advent of computer technology, the automation of chemical analysis
became possible. Computer controlled chemical analysis reduced analysis time,
increased sample throughput, and improved the reproducibility of measurements.
In the first stages of computer controlled systems, the steps of batch analysis were
mechanized. The samples were transported in disposable containers on a conveyor belt,
while reagents were added and mixed with the sample by a mechanical stirrer. Although
these mechanized analyzers had distinct advantages, the machinery took up a large
amount of space and were expensive to operate.70
The next stage in the development of automated analytical systems appeared with
the advent of flow analytical techniques. Flow operations are the sequential movement of
liquids through tubes. With flow operations, microvolumes of sample can be metered
and manipulated by pumping devices. Flows can be mixed, stopped, restarted, reversed,
split, recombined, and sampled. Also, since the solution is contained within closed
tubing the affects of evaporation can be avoided. The tubing provides a repeatable
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path(s) for solution movement and an environment for reproducible mixing of
components.
Flow analytical systems can be miniaturized and combined with microfabricated
sensors to make lab-on-chip devices.7, 14, 25, 46, 57, 70, 94 Flow analytical systems have
shown unique advantages when combined with electrochemical sensors.17, 56, 70, 91
Automated flow analytical systems are used where a large number of samples are
analyzed (e.g., the food/beverage industry, for environmental monitoring, and the
pharmaceutical industry).42, 58, 82, 84 One of the main tasks of my doctoral work was the
development of an Automated Flow Analytical System (AFAS) for monitoring the
concentration of the anesthetic drug propofol during anesthesia.
Propofol (2,6 – diisopropylphenol) is formulated in an oil-in-water emulsion that is
1% propofol, 10% soybean oil, 1.2% purified egg lecithin, 2.25% glycerol and 0.005%
EDTA. The soybean oil and egg phospholipids are solubizing agents. The EDTA
inhibits bacterial growth. Glycerol adjusts the osmotic pressure.
The average induction time for propofol is between 40 and 78 seconds.19, 85
Propofol is readily metabolized by the body, with less than 1% of the drug excreted
unchanged.85 Propofol is metabolized mainly via the liver (70%) and the kidneys
(30%).49, 85 The brain and lungs do not contribute to total body clearance of propofol.85
The therapeutic concentration range of propofol in blood is between 0.25 and 16
μg/mL.60, 61, 74, 85 This translates into a serum concentration between 1.4 and 89 μM.85
Table 1-1 correlates propofol blood concentration to the Ramsay Sedation Scale.
The Ramsay Sedation scale describes a patient‟s level of consciousness. McKeage et al.
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reported that a propofol blood concentration between 0.25 and 2 μg/mL correlate to a
Ramsey sedation score of 2 – 5.61

Table 1-1: Correlation of propofol blood concentration with the level of consciousness.
Concentrations with the „a‟ superscript are in the presence of fenantyl. The table was
reproduced and modified from McKeage et al.61 Data was added from Iwakiri et al., Liu
et al., and McKeage et al.39, 55, 61
Propofol Concentration
Ramsay Sedation Scale
Level of Sedation
[μg/mL]
Awake Levels
1
Agitated, anxious, and/or
restless
0.25a
2
Cooperative, oriented and
tranquil
a
0.6
3
Responds to commands
Asleep Levels
1a
4
Brisk response to stimulus
a
2
5
Sluggish response to stimulus
>2 a
1.7
3.5
2.1a
6
Unconscious, no response to
1.9
stimulus
a
- 15.2
9.6
No response to surgical
stimulus

Propofol‟s duration of effect (i.e., the length of time propofol has a
pharmacological effect) is typically between 5 and 15 minutes. It is dependent on the
level and length of sedation.61, 85 Figure 1-1 shows the duration of effect for light
sedation. For propofol infusion times of 10 hours or less, recovery from anesthesia is
within 5 to 15 minutes. For infusion time longer than 10 hours, recovery is delayed
because of the saturation of propofol in the fatty tissues. Figure 1-1 shows that even after
a 10 day infusion, propofol is eliminated fairly quickly, and the patient is awake within
25 minutes.
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Figure 1-1: Duration of propofol effect following the termination of infusion. Figure
taken from Diprivan® Injectable Emulsion.19

It has been shown that propofol, like many other drugs, complexes with proteins
in the blood. Evidence has been shown that albumin, one of the most prevalent serum
proteins, complexes propofol. There is some debate about the number of propofol
molecules that are complexed per albumin protein. Early studies by Mazoit et al. suggest
that there are more than 20 possible complexation points.60 However, more recent
studies have demonstrated that there are only two regions on the albumin protein that
bind propofol.6, 54 One of the regions was shown to have greater affinity for fatty acids.
This region would most likely bind a fatty acid molecule instead of propofol. To
calculate the concentration of free propofol in serum, the stoichiometry of the propofol
albumin complex and the binding constants must be known. It has been estimated that at
an EC50 (the concentration of the intravenous anesthetic in which 50% of patients will
not respond to surgical stimuli)55, 74 concentration of 50 μM, there is only 7 μM of free
propofol (i.e., non-complexed ) in the blood.54, 60 Lui et al. have reported a dissociation
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constant for the albumin-propofol complex (Kd) of 65 μM.54 Kd indicates the
concentration of the ligand (i.e., propofol) in which 50% of the proteins will have the
ligand bound.
Current Methods of Detection and Monitoring of Sedation
Current methods used by clinicians to qualify the level of sedation are Observers
Assessment of Alertness/Sedation (OAAS), Guedel‟s classification, and Bispectral index
(BIS).6, 20, 76 OAAS uses the patient‟s response to stimuli to assess the depth of sedation.
Guedel‟s classification uses physical signs, such as automatic breathing, eyelid reflex,
and eyeball movements to assess the depth of sedation. BIS is an algorithm that
interprets a patient‟s electroencephalogram to determine the level of consciousness.
Current offline methods of detection of propofol in blood are high performance
liquid chromatography (HPLC) and gas-liquid partition chromatography (GLPC).22, 27, 45,
73

Guitton et al. using gas chromatography were able to detect concentrations from 0.01

to 10 μg/mL of propofol in whole blood.27 Vree et al. using HPLC reported a detection
limit of 0.10 μg/mL.45 Although these offline methods have adequate detection limits,
they are unsuitable for bedside measurements because: (i) the analysis time (sampling,
sample treatment, measurement, etc.) is much greater than propofol‟s duration of effect;
(ii) an extensive sample treatment is required before the measurement; and (iii) they
require complex instrumentation that is often large/bulky.
Other methods of propofol detection include monitoring propofol in human
breath.34, 36, 62, 78 In an experiment by Hornuss et al., real time measurements of propofol
in expired breath samples were correlated to propofol blood concentrations.36 However,
there was a large patient-to-patient variation.
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Although not approved for use in the United States, target-controlled infusion is a
common practice around the world for intravenous anesthetics. The systems use
pharmacokinetic and pharmacodynamic models to predict propofol blood concentration.1
These systems control the flow rate of an infusion pump and estimate the propofol
concentration in blood based on the volume and concentration of propofol administered.
In combination with a propofol sensor, these systems offer an attractive possibility for
safe drug delivery based on measured concentrations of propofol in patients.
1.1

Problem to be Addressed
Propofol (Diprivan®) is one of the most wildly used anesthetic drugs for

inductance and maintenance of sedation. It is extensively used for critical care patients
receiving mechanical ventilation. In most cases, the goal of clinicians is to keep the
patient slightly sleepy and pain free.18 However, current standard dosing paradigms,
which use weight, age, and sex of the patient to determine dosage amounts, are not
universal to all patients. Consequently, some patients may be under-sedated while others
may be over-sedated. Patient under-sedation can affect patient comfort, proper patientventilator synchronization, and blood oxygenation.15 Patient over-sedation can result in
the development of propofol infusion syndrome (PRIS).
PRIS is characterized by many physiological dysfunctions, such as metabolic
acidosis, hemodynamic changes, acute renal failure, rhabdomyolysis,
hypertriglyceridemia, hyperlipidemia, and cardiac dysfunction.67 In rare cases PRIS can
even lead to patient death. The triggering factors for PRIS include long term use of high
doses of propofol, exogenous catecholamine or glucocorticosteroid administration,
inadequate carbohydrate intake, and subclinical mitochondrial disease.67, 97

6

Priming Factor
Critical illness
Acute disease of the central nervous system, sepsis, burns, trauma, pancreatitis

Triggering Factor
Glucocorticoids

Increased proteolysis

Myopathy

Rhabdomyolysis

Triggering Factor
Catecholamines

Triggering Factor
High-dose propofol
> 4mg/kg per hour
+
> 48-hour duration

Myofibrillar degeneration

Mitochondrial inhibition
Heart failure
Increases levels
of free fatty acids

Shock

Arrhythmia

Metabolic acidosis

Renal failure

Figure 1-2: Diagram of the priming and triggering factors of PRIS. Reproduced and
modified from Zaccheo et al.97

While there are multiple triggering factors that contribute to the onset of PRIS, the
main „priming factor‟ is critical illness, which is described by Vasile et al. as an “acute
disease of the central nervous system: sepsis, burns, trauma, and pancreatitis”.87 Figure
1-2 shows the proposed priming and trigger factors of PRIS and its physiological
consequences.
Children require larger doses of propofol for induction and maintenance of
sedation. Therefore, they are more predisposed to the development of PRIS.16, 85
Although the exact number of PRIS cases are unknown, Crozier estimates that PRIS
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affects every 1 in 270 patients.16 Because of these situations, a method for bedside
monitoring of propofol is needed. To our knowledge, there are no systems that monitor
propofol blood concentration in patients under sedation or anesthesia. The goal of the
current work was to demonstrate the feasibility of propofol monitoring using an
electrochemical detector. The final objective of the project is to provide a feedbackcontrolled drug delivery device to maintain optimal propofol blood concentration in
patients.
1.2

Design of the Automated Flow Analytical System
Our group works on the development of short turnaround time (STAT) sensing

systems using microfabricated planar electrochemical sensors for point of care testing
(POCT). The development requires the evaluation of the performance characteristics of a
large number of electrodes and analysis of a large number of samples. My task was to
create a multipurpose Automated Flow-Analytical System (AFAS) to evaluate the
performance characteristics of different sensors using various flow-analytical methods.
The system would encompass sampling, sample transport/solution flow, and
voltammetric detection. Details of the AFAS can be found in Appendix A.
The AFAS is composed of a flow-through electrochemical detector cell, a computer
controlled valve positioner (actuator) in combination with a multi-position valve
(sampling), a peristaltic pump (solution handling), and a potentiostat (measurement). The
development of the AFAS included:
1. Selection of specific instruments to be used in the AFAS
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2. Selection of a control program platform (i.e., programming language), and design
of a control program and graphical interface
3. Testing the performance characteristic of the AFAS
1.2.1

Selection of Instruments

The criteria used for instrument selection are:
1. The instrument can be electronically controlled via a computer interface (RS-232,
USB, DAQ, etc.).
2. The instrument has specifications that meet the requirements for an automated
flow analytical system.
3. If possible, utilize instruments already in the lab.
Using these selection criteria, the following instruments were chosen as
components of the AFAS. The Modular Valve Positioner (MVP) (367898, Hamilton
Company, Reno, NV) was selected because it could be used in combination with a
variety of easily attachable valves. In the AFAS the MVP is used in combination with
the 6-port Distribution Valve (6-PD) (Model: 36781) or the 6-port Loop Valve (6-PL)
(Model: 38760) (Hamilton Company, Reno, NV). These valves allow the selection of up
to 6 solutions (reagents or samples), and the implementation of a wide variety of
sampling and analysis schemes. We were also able to utilize two instruments, a
peristaltic pump and potentiostat, which were already in the lab. The Miniplus3
Peristaltic Pump (F1155006, Gilson Incorporated, Middleton, WI) has the ability to start,
stop, reverse, and control the rate of solution flow. The CV-27 Cyclic Voltammagraph
potentiostat (Model MF9030, Bioanalytical Systems Incorporated, West Lafayette, IN)
can implement a variety of electrochemical techniques. When combined with the PA-1
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Pre-Amplifier (Model MF2200) amperometric measurements can be made in the
nanoampere current range.
Figure 1-3 shows a schematic view of the instrument communication/control and
fluid pathways of the AFAS. The computer contains the control program that
communicates with each instrument in the system through various interfaces. The
potentiostat is connected to the computer via the NI-6221 DAQ card (National
Instruments Corporation, Austin, TX) and an USB port. The Modular Valve Positioner
(MVP) is connected directly to the computer via the COM1 serial port. The peristaltic
pump is connected to the computer via the 506C Interface (Gilson Incorporated,
Middleton, WI) and the COM2 serial port. Analytes/reagents are selected by the MVP.
The peristaltic pump is used to flow the selected analyte/reagent from the sampling point
to the detector. The selected analyte/reagent passes through the flow through
electrochemical detector cell, which houses the electrode/sensor, and is deposited in a
waste container.
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COM2

USB

NI-6221

Gilson 506C
Interface

Computer
COM1

BAS CV27
BAS PA1
Potentiostat

GSIOC Cable

Flow-Through
Electrochemical
cell

Gilson Minipulse3
Peristaltic Pump

Communication Lines

Waste

Fluid Lines

Hamilton MVP
Sampling Valve
Samples

Figure 1-3: Block diagram of the communication control and the fluid flow pathways in
the AFAS

1.2.2

Design of the Control Program
LabVIEW (National Instruments Corporation, Austin, TX) was chosen as the

control program platform because it allows one to: (1) integrate and control multiple
instruments, (2) design a sophisticated, user-friendly graphical interface, and (3) design a
system that can evolve according to the needs of researchers.9, 10, 81 LabVIEW is widely
used and has far-reaching applications in academia and industry.12, 13, 21, 23, 37, 88 The
control program was designed using the following objectives:
1. Allow the sequential activation of the system‟s instruments to perform flow
analytical tasks with electrochemical detection
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2. Automatically save experimental data, parameters, and procedures
3. Save experimental data in a simple ASCII format for post hoc analysis
4. Allow for the recall of saved experimental procedures
5. Design a user-friendly graphical interface that effectively uses the available
computer display space and provides the user with information on the status of
experiments
The Flow Analysis (FA) and Flow Injection Analysis (FIA) control programs, in
combination with the AFAS (FA-AFAS/FIA-AFAS), allow for the implementation of
complex flow analytical tasks. Both programs allow the user to select and configure the
valve attached to the MVP, and input an experiential procedure. The FA program allows
the user to control when (in which step in the experimental procedure) to apply an
electrochemical technique. The user can choose from two electrochemical techniques,
cyclic voltammetry (CV) or chronoamperometry (CA). In the FIA control program only
CA can be used, and there is no user control of when to start and stop the CA experiment.
A constant potential is applied throughout the entire experimental procedure.
The FA program was designed for short-term application of an electrochemical
technique (i.e., seconds to minutes). The FIA program was designed for continuous longterm (≤ 2 hours) chronoamperometric experiments.
In cyclic voltammetry the potential of the working electrode is scanned according
to a triangular potential waveform. The current flowing through the working electrode is
recorded as a function of the applied potential. Figure 1-4 shows an example of a typical
CV waveform and the i-E response for a macroelectrode and microelectrode.
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Macroelectrode
t

Microelectrode
E

Figure 1-4: Example cyclic voltammagrams for a reversible O + ne- → R redox process
for a macroelectrode and microelectrode. Inset: Applied potential-time excitation
waveform in a cyclic voltammetry experiment.

In cyclic voltammetry, the peak current of a macroelectrode and the steady-state
current of the microelectrode are directly proportional to the concentration of the
oxidized [O] or reduced [R] form of the analyte in the bulk of the solution. The peak
current for a reversible couple is given by the Randles-Sevcik equation (Equation 1):

i p  (2.69  105 )n 3 2 ACD1 2 v1 2

(1)

13

where n is the number of electrons, A is the electrochemically active surface area, C is the
concentration, D is the diffusion coefficient, and v is the potential scan rate. The steadystate current for a disk microelectrode is given by Equation 2:

i ss  4nFCDr

(2)

where F is the Faraday constant and r is the radius of the disc.
In chronoamperometric methods, the potential of the working electrode is stepped
from a potential at which no faradic reaction occurs at the electrode surface, to a potential
at which the surface concentration of the electroactive species drops to zero.89 The first
term in Equation 3 is the Cottrell equation, which describes the current-time response of a
macroelectrode.

nFAD 1 2 C
i d (t ) 
 4nFDCr
 1 2t1 2

(3)

t is time, and all other parameter are as stated previously. Figure 1-5 displays a CA
waveform and the i-t response transients for a macroelectrode and microelectrode. The
steady-state current for a disk microelectrode is given by Equation 3. At long time
periods Equation 3 is dominated by the second term in the equation.
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Figure 1-5: Example chronoamperometric current-time response transients for a
reversible O + ne- → R redox process with (a.) macroelectrode and (b) microelectrode.
Inset: Applied potential-time excitation waveform in a chronoamperometric experiment.

1.3

Detection Scheme
The voltammetric determination of propofol (2,6 -diisopropylphenol) is

challenging. Similar to other phenolic compounds, detrimental electrode fouling occurs
when measurements are performed in an aqueous environment. Over time, the product of
the electrochemical oxidation deposits onto the working electrode surface, causing a
change in the electrochemical signal in repeated measurements within the same sample.
This process is termed as electrode fouling. Electrode fouling limits the applicability and
the lifetime of a propofol sensor. The electrode fouling can be drastically reduced if the
electrochemical oxidation of propofol is performed in an organic environment.44, 47
Consequently, our group is working on the development of an organic film-based sensor
for the quantitative measurement of propofol.
An organic film coated sensor has been shown to have several advantages
compared to conventional working electrodes (i.e., without specific coatings). With the
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organic film coated sensor: (i) the electrode fouling is significantly reduced; (ii) the
influence of common electrochemical interferences in biological samples, like ascorbic
acid and p-acetamido phenol, is minimized; and (iii) the detection limit of the propofol
measurement is improved.47

Figure 1-6: Schematic view of propofol detection scheme. A planar electrochemical cell
is coated with a thin layer of the organic film. When exposed to an aqueous propofol
sample, propofol partitions into the organic film, and is oxidized on the surface of the
working electrode (WE) when an adequate potential is applied. CE – counter electrode.
RE – reference electrode. A and A- are the oxidized and reduced forms of a reagent in
the membrane.

The organic film consists of high molecular weight polyvinyl chloride (PVC), 2nitrophenyl octyl ether (o-NPOE), tetradodecylammonium-tetrakis (pentaflourophenyl)
borate (TDDA-TPFPhB), and an organic salt, either potassium tetrakis
(pentaflourophenyl)borate (KTPFPhB) or sodium tetrakis[(3,5-bis(triflourmethyl)]
phenylborate (NaTFPhB). The PVC is the support structure of the organic film. The oNPOE, a plasticizer, forms the organic environment in the film, and allows lipophilic
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molecules (i.e., propofol) to preferentially partition into the film. The TDDA-TPFPhB is
an organic electrolyte that helps reduce the resistance of the film. TDDA-TPFPhB is a
highly lipophilic molecule that is not soluble in water.
A film solution is made by dissolving the film components in tetrahydrofuran
(THF). The film is cast onto the surface of the planar electrochemical cell by spin
coating. To make it possible to coat the entire electrochemical cell with a thin layer of
the plasticized-PVC film, a planar glass chip patterned with a microfabricated working
(WE), counter (CE), and reference electrodes (RE) is used. It is beneficial to coat the
entire electrochemical cell, not just the working electrode, with the organic film. In this
arrangement no current is flowing across the solution/film interface, and the possibility of
fouling on the surface of the film is reduced. However, this arrangement requires that the
electrodes are patterned close to each other to minimize the possible iR drop in the
membrane.
Figure 1-6 illustrates the detection scheme with the organic film coated
electrochemical cell. During a propofol measurement, the membrane modified electrode
is immersed in an aqueous propofol sample. Propofol partitions from the sample solution
into the organic film. When sufficient potential is applied to the working electrode,
propofol is oxidized on the surface of the working electrode, and the counter electrode
will reduce a component in the membrane, most likely oxygen (from the sample). The
oxidation current is directly proportional to the propofol concentration in the film, which
is in equilibrium with the aqueous sample. Consequently, the measured current is
directly proportional to the propofol concentration in the sample.
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1.4

Objectives

The objectives of this dissertation are:
1. Show of the performance characteristic of the AFAS in combination with a flowthrough detector cell using planar, microfabricated electrochemical cells. This
task includes: (i) developing a thin-layer flow through cell to be used with
microfabricated planar electrodes that is adequate for flow or stopped flow
measurements; (ii) metering and electrochemically analyzing microliter to
milliliter quantities of analyte/solutions; (iii) monitoring the changes in
concentration under varied flow conditions by implementing a variety of flow
analytical techniques; and (iv) designing experimental procedures for continuous
monitoring experiments. The characterization of the AFAS is discussed in
Chapter 2.
2. Evaluate characteristics of a membrane coated voltammetric sensor when it is
incorporated into the automated flow analytical system (AFAS). This task
includes: (i) the characterization of a thin, PVC membrane coated electrochemical
cell using ferrocenemethanol as a model compound; (ii) demonstrating the
influence of the membrane thickness on the electrochemical signal; and (iii)
comparing the performance characteristics of voltammetric analysis in the AFAS
using microfabricated sensors with or without membrane coating. The response of
the membrane coated sensor to ferrocenemethanol is discussed in Chapter 3.
3. Adapt the AFAS for propofol measurements and demonstrate performance
characteristics of a membrane coated propofol sensor when it is incorporated into
the AFAS. This task includes: (i) the determination of the precision and accuracy
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of propofol measurement in the physiologically relevant concentration range; and
(ii) determination of the effect of interfering compounds, such as ascorbic acid,
and para-amidophenol, on the propofol measurement. The response of the
membrane coated sensor to propofol is discussed in Chapter 4.
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2
2.1

AUTOMATED FLOW ANALYTICAL SYSTEM CHARACTERIZATION
Valves
Selection and sampling of solutions is performed using the 6-Port Distribution (6-

PD) and the 6-Port Loop (6-LP) valves. A schematic of the valves depicting their fluidic
profiles are shown in Figure 2-1. The 6-PD is a sampling valve, and the 6-PL is an
injector valve.

6-Port Distribution Valve
Carrier
Solution

Solution 1
Solution 6

6-Port Loop Valve
To Detector
Carrier
Solution

Solution 2

Sample
Sample In
Out

Solution 3

Solution 5

Sample Loop

Solution 4

LOAD

INJECT

a.

b.
Figure 2-1: Schematic representation of the flow pattern of the (a) 6-Port Distribution
Valve and (b) the 6-Port Loop valve which are used in combination with the MVP. Taken
and modified from Hamilton Company Valve Flow Diagram.32

Each valve has an internal cylinder that can be rotated in the clockwise or
counterclockwise direction. The rotation of the cylinder in the 6-PD valve allows the
selection of a solution from 6 different input ports (Figure 2-1a). The rotation of the
cylinder in the 6-PL valve allows the selection between Load and Inject flow
configurations (Figure 2-1b). In the Load position an attached sample loop is filled with
a sample solution, while a carrier solution bypasses the loop and flows directly to the
detector. In the Inject position the sample loop is connected to the carrier stream, and the
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sample is transported by the carrier solution to the detector. The technique in which a
bolus liquid sample is injected into a flowing stream of carrier solution and is carried by
the flow to the detector, is called Flow Injection Analysis (FIA).80
FIA was developed for the rapid analysis of small sample volumes. The use of
small sample volumes is beneficial if the sample is expensive, precious, limited, or toxic
to the environment. In FIA as the sample is transported from the injection point to the
detector it becomes dispersed. The dispersion in a flow analysis system is highly
reproducible, and can be controlled through the experimental conditions. Consequently,
FIA can be used for the controlled dilution and analysis of highly concentrated samples.
Figure 2-2 displays the concentration profile of an injected sample plug upon its injection
(C0), and the dispersed sample plug at a certain distance from the injection point. The
sample is dispersed both radially and longitudinally. The dispersion depends on the
experimental conditions and the physical parameters of the flow path. The dispersion of
the sample is given by Equation 4:

D  C 0 C max

(4)

where D is the dispersion factor, C0 is the injected sample concentration, and Cmax is the
maximum dispersed concentration.
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Figure 2-2: The initially injected sample zone (top left) disperses as it moves through the
flow path (top right). The concentration profile at the initial injection, with a
concentration equal to the sample concentration C0 (bottom left), changes to a dispersed
concentration gradient with the maximum concentration, Cmax, at the peak. Taken from
Ruzicka et al.70

With the 6-PL valve, to change the injected sample volume, the sample loop has
to be replaced with a different sample loop. The 6-PL valve can only sample a single
analyte.
The 6-PD valve can be transformed into an injector valve by using time-based
injections. In this configuration one of the six ports is designated for the carrier solution,
and another is designated for the sample. The other available ports may be used for
calibration standards. To perform a flow injection the valve is rotated from the carrier
port to the sample port, and the sample is flowed for a specific amount of time. The flow
rate of the solution determined the amount of sample injected. The valve is then rotated
back to the carrier solution, which washes the sample to the detector.
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2.2
2.2.1

AFAS Operational Flow Schemes
Flow Injection Analysis Program controlled AFAS (FIA-AFAS)
The FIA-AFAS is used for flow injection analysis. In a FIA-AFAS experiment a

potential is applied to the working electrode throughout the experiment, and the current
flowing between the working and counter electrodes is continuously measured. The
current is directly proportional to the concentration of the solution in contact with the
working electrode. Consequently, the i-t transient has the same shape as the
concentration profile shown in Figure 2-2 (bottom right).
Figure 2-3 shows an AFAS operational scheme for a FIA experiment utilizing the
6-PL valve. The flow scheme shown in Figure 2-3 will be referred to as Scheme 1. As
the sample loop is filled from the sample receptacle (i.e., beaker, patient, vial, etc.) by
Pump 2, a carrier solution is pumped by Pump 1 through the flow-through detector cell
and then to a waste receptacle. The flow-through detector cell contains a planar
microfabricated chip, which is connected to the potentiostat. When only the carrier
solution is within the flow-through detector cell, a background current (a capacitive
current unrelated to a faradic process) is measured. Once the sample loop is filled, the
valve is rotated to its inject position. The carrier solution washes the sample plug into the
flow-through detector cell. As the electroactive sample comes in contact with the
electrode, the electrochemical reaction at the working electrode generates a current
proportional to the concentration. As the plug exits the flow-through detector cell the
current decreases back to the background current. To minimize the amount of necessary
sample and waste, the sample can be recycled back to the sample receptacle.
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If the rate of concentration change in the sample receptacle is slow, compared to
the frequency of injections and measurements, FIA is adequate to „continuously
monitor‟ changes in the sample concentration. This is analogous to the digital sampling
and reconstruction of an analog signal.

.
Pump 1

Flow-through
cell

Injector
Valve

Waste
Potentiostat
Carrier
Patient

Pump 2

Figure 2-3: Scheme 1. Flow injection analysis flow operational scheme utilizing the 6PL valve.

The FIA-AFAS can also be used in combination with the 6-PD valve as shown in
Figure 2-4. This flow operational schematic is referred to as Scheme 2. As stated
previously, the 6-PD valve can be used as a time-based injector valve with single ports
designated for the sample and carrier solutions, and the other ports available for
calibrating standards. Figure 2-5 shows an example i-t transient in which 4 standard
solutions, of increasing concentration, were injected in the carrier stream followed by the
injection of the sample. The use of calibrating standards allows the construction of a
calibration curve relating the peak height of the signal to the concentration. The
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calibration curve can be used for the quantification of unknown sample concentrations
and to compensate for possible drift in the sensor.

Sampling
Valve

Flow-through
cell

Waste

Potentiostat
Pump
Standards
Carrier

Patient

Figure 2-4: Scheme 2. Flow injection analysis flow operational scheme utilizing the 6PD valve.
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Figure 2-5: Example current-time transient of a FIA scheme utilizing the 6-PD valve for
the injection of four standard solutions and the sample.

2.2.2

Flow Analytical Program controlled AFAS (FA-AFAS)
The FA-AFAS is a general purpose system, which can implement different

electrochemical methods with a variety of fluidic and sampling schemes. The sample
solution may be stopped in the flow-through cell, or continuously pumped during the
measurement. The stopped flow option is beneficial for processes/reactions with slow
kinetics and also minimizes waste. The continuous flow option increases the flux and
therefore offers a higher sensitivity.
Both of the flow operational schemes shown in Figures 2-3 and 2-4 can be
implemented in combination with the FA-AFAS. With injected samples, the sample
must be moved into the flow-through detector cell and the solution flux stopped before a
measurement is performed.
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The measured current depends on the concentration of the sample within the flowthrough detector cell. If the dispersed sample volume is larger than the volume of the
flow-through detector cell, the measured current reflects a section of the concentration
profile of the dispersed sample that is within the flow-through detector cell. Figure 2-6
shows a concentration profile for an injected sample plug and displays CVs at 3 specific
time instances corresponding to regions of the dispersed sample plug. The transient
concentration, related to the progression of the sample plug through the flow-through
detector cell, can be constructed from consecutive measurements reflecting the
consecutive concentration regions. Unlike the FIA-AFAS, the FA-AFAS does not record
the entire transient related to the progression of the sample plug through the flow-through
detector cell, but performs a measurement at a certain region of the dispersed plug. For
maximum sensitivity, measurements are performed in the region of maximum
concentration (Cmax).
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Figure 2-6: Concentration profile of an injected sample plug in the flow channel at a
certain distance from the injection point, e.g., in the electrochemical flow-through
detector cell. Inserts: CV measurements performed with the FA-AFAS at different time
points as the dispersed sample passes through the flow-through detector cell.

Figure 2-7 shows a flow operational scheme that can be implemented with the
FA-AFAS (Scheme 3) to characterize electrodes. The 6-PD sampling valve is connected
to standard solutions of varying concentrations. The valve selects a standard, and the
pump moves the solution into the flow-through detector cell. Electrochemical
measurements can be performed under stopped-flow or flowing conditions. The current
measured in the various standards can be used to construct a calibration curve.
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Figure 2-7: Scheme 3: Calibration scheme utilizing the 6-PD valve.

Schemes 1 through 3 are just examples of flow schemes that may be performed
with the AFAS. Other schemes and procedures may be developed according to the user‟s
needs.

2.3

AFAS Operating Parameters
The FA program allows programmed measurement. In experiments with a

multitude of washing, conditioning, and reaction steps, the user can program when to
perform the electrochemical measurement. This feature is beneficial when the
continuous polarization of the working electrode is disadvantageous.
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Figure 2-8: Experimental protocol task-pane for the FA control program.

Figure 2-8 displays the experimental protocol task-pane for the FA program.
This task-pane allows the user to input an experimental protocol using one line/row for
each step in an experimental procedure. Each step in the experimental protocol is
composed of five elements (a) Valve Position (b) Pump RPM, (c) Pump Time, (d) Wait
Time and (e) Measure, which are described as follows:
a. Valve Position – This control allows the user to select a specific valve position for
a specific protocol step.
b. RPM – The RPM (rotations per minute) control allows the user to select the
rotation speed of the peristaltic pump for a specific protocol step.
c. Pump Time – The pump time control specifies how long the pump will be active
for a specific protocol step.
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d. Wait Time – The wait time control stops the pump, and the system waits the
specified time for a specific protocol step.
e. Measure – The measure control specifies if a measurement will be taken during a
specific step of the experimental protocol. This is a Boolean control. It is either
ON or OFF. A green, oval LED is used for this control. When the LED is brightgreen measurement is ON at that step. When the LED is opaque-green
measurement is OFF for that step.
The experimental procedure task-pane in Figure 2-8 displays a three step timeinjection procedure similar to Scheme 2. Position 1 of the valve is connected to the
carrier solution, and Position 2 is connected to the analyte solution. The FA program
interprets the experimental procedure as follows:
1. Load the 1st step in the experimental procedure
a. Send electronic command to the MVP and rotate the valve to Position 1 to select
the carrier solution.
b. Send electronic commands to the peristaltic pump to (1) set pump tumbler
rotation speed to 5 RPM, and (2) activate tumbler rotation which initiates flow of
carrier solution.
c. The system then counts down the pump time from 30 seconds to zero (i.e., flows
the carrier solution for 30 seconds).
d. The wait time is 0, do nothing. Continue flowing carrier solution.
e. Measure is not active, do nothing.
2. Load the 2nd step in the experimental procedure.
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a. Send electronic command to the MVP, and rotate the valve to Position 2 to select
the analyte solution.
b. Send electronic commands to the peristaltic pump to (1) set pump tumbler
rotation speed to 5 RPM, and (2) activate tumbler rotation which initiates flow of
analyte solution.
c. The system then counts down the Pump Time from 60 seconds to zero (i.e., flows
analyte solution for 60 seconds).
d. Send an electronic command to stop pump. The system counts down the wait
time from 3 to zero (i.e., stops flow of analyte solution and wait for 3 seconds).
e. The Measure Boolean is active. The system applies the selected electrochemical
technique and reads the response from the electrode/sensor. The measured
current is directly proportional to the concentration of the sample located
within the flow-through detector cell (see Figure 2-6).
3. Load the 3rd step in the experimental procedure.
a. Send electronic command to the MVP, and rotate the valve to Position 1 to select
carrier solution.
b. Send electronic commands to the peristaltic pump to (1) set pump tumbler
rotation speed to 1 RPM, and (2) activate tumbler rotation which initiates flow of
carrier solution.
c. The system then counts down the Pump Time from 200 seconds to zero (i.e.,
flows the carrier solution for 200 seconds and washes the analyte solution
from the flow-through detector cell).
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d. Send an electronic command to stop pump. The system counts down the wait
time from 3 to zero (i.e., stop flow of carrier solution and wait for 3 seconds).
e. The Measure Boolean is active. The system applies the selected electrochemical
technique and reads the response from the electrode/sensor. A non-faradic
current will be measured because no electroactive species are within the
flow-through detector cell.
For the protocol in Figure 2-8, two measurements were performed.
Figure 2-9 displays the experimental protocol task-pane for the FIA program.
Essentially the same experimental procedure is shown, except there is no step-by-step
measurement control. A potential is applied continuously to the working electrode
throughout the experimental procedure. The FIA program interprets the experimental
procedure the same as above, only step „e‟ is eliminated. For the protocol shown in
Figure 2-9 only one measurement is performed, and the measured current is directly
proportional to the concentration of the sample plug as it flows through the flow-through
detector cell.
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Figure 2-9: Experimental procedure task-pane for the FIA control program.

Both the FA and FIA programs have the ability to automatically repeat an
experimental procedure an user-specified number of times via a cycle control. This
allows for the easy construction of long-term experiments.
2.4
2.4.1

Experimental
Microfabricated Planar Electrode Chip
Planar electrochemical cells were fabricated by Aegis Technologies Group, Inc.

(Huntsville, AL). The electrochemical cells were patterned on 11.67x11.16 mm glass
chips with a gold microdisk electrode array (MEA), and two gold macroelectrode with
surface areas of 0.0125 and 0.158 cm2. The larger macroelectrode was utilized as a
counter electrode and the smaller as a reference electrode. The MEA was utilized as the
working electrode. The MEA is composed of individual disk electrodes which are
interconnected and arranged in a hexagonal fashion. Two MEA chip configurations were
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used: (i) a 2 μm MEA with individual disk diameters of 2 μm and a 20 μm center-tocenter disk separation, and (ii) a 10 μm MEA with individual disk diameters of 10 μm
and a 150 μm center-to center disk separation. Figure 2-10 shows a picture of a 2 μm
MEA chip. Both chip configurations have a MEA diameter of 3 mm and an
electrochemical cell diameter of 6 mm.
The limiting current for a microdisk electrode array with recessed individual
electrodes is given by Equation 5:

iL  N

4nFDCr
4l
1
r

(5)

where N is the number of individual microdisk electrodes in the array, n is the number of
electrons, F is the Faraday constant, D is the diffusion coefficient, C is the concentration,
r is the radius of an individual microdisk, and l is the depth of the recess. Unfortunately,
Equation 5 could not be used to describe the limiting current of the 2 μm MEA. The
actual 2 μm MEA geometry did not meet MEA design parameters.28, 29 Consequently,
their current response deviated from the theoretical expectations.
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Reference
Figure 2-10: Left: Picture of a 2 μm MEA chip with microelectrode array, counter, and
reference electrodes. The diameter of the microelectrode array is 3 mm. The diameter of
the electrode cell is 6 mm. A picture of the boxed area is shown on the right. Right:
Magnified view (200x) of the MEA, each dot is an individual microdisk electrodes with
diameters of 2 μm.

In some experiments planar interdigitated band array (IDA) electrodes were used
as working electrodes. The IDA chips were fabricated by Aegis Technologies Group Inc.
An IDA is made up of closely-spaced parallel microbands in which every other band is
interconnected.86 The interconnection of these bands forms the two „fingers‟ of the IDA.
The smaller the band gap between the fingers of the IDA, the higher the collection
efficiency and amplification.65 The 2 μm IDA has a band-gap and band separation width
of 2 μm. The chip also contains two gold macroelectrodes with surface areas of 0.013
and 0.66 cm2. The smaller of these macroelectrode served as a reference electrode, while
the larger served as a counter electrode. In our experiments, the two „fingers‟ of the IDA
were interconnected, and the IDA was used as a macroelectrode.
2.4.2

Thin-Layer Flow-Through Detector Cells
Two thin-layer flow-through detector cells were designed, fabricated, and tested

in combination with the AFAS. The first thin-layer flow through cell was comprised of
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two Teflon blocks (Figure 2-11). The top block contains the inlet and outlet ports, and a
silver rod that forms a silver coplanar disk. The silver disk was used as a reference
electrode. The bottom block is comprised of two gold rods which form two disk-shaped
coplanar macroelectrodes with surface areas of approximately 0.034 cm2. One of the
gold electrodes was used as the working electrode, and the other electrode was used as
the counter electrode. A 0.002 inch thick Teflon gasket was used to create a chamber
volume of approximately 3.5 μL. The top and bottom blocks were pressed together using
four screws located at the corners of the Teflon blocks. The inlet and outlet ports are
connected to the MVP and pump, respectively.
.
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Screw bore
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Ag reference
electrode

Inlet/Outlet
Ports

Ag Reference
Electrode
Top

Au Working
3.5μL Teflon and Counter
Gasket
Electrodes
Middle

Inlet port

Outlet port

Teflon
spacer

Bottom
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Figure 2-11: Teflon block thin-layer flow through cell. Left: Planar view of the top and
bottom Teflon blocks. The top block contains the inlet/outlet ports and a Ag reference
electrode. The bottom block contains two Au electrodes which are used as working and
counter electrode. A 0.002 inch thick Teflon gasket is placed between the top and bottom
blocks to form a 3.5 μL volume chamber. Right: Cross-sectional view across the center
of the thin-layer flow through cell composed of two Teflon blocks. Solution enters into
the inlet port, flows through the flow-through detector cell and exits through the outlet
port. The inlet/outlet ports are connected to tubing by ferrules.
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The second flow through cell was designed to be used in combination with planar
microfabricated electrode chips. Figure 2-12 displays the schematics of the flow through
cell. All dimensions are in millimeters. The top and middle blocks were composed of
polycarbonate. Polycarbonate was chosen because it is transparent, scratch resistant, has
a low non-specific absorption,26 and is easily machined. The clamp and the bottom block
were made of stainless steel.

Sliding rod
bore holes

Top block
Middle block
Bottom block
Clamp
Fixing screw hole
Figure 2-12: Clamp-style thin layer flow through cell. Flow through cell is designed to
be used with microfabricated planar chips. The cell is composed of a clamp and 3 inner
blocks that move on sliding rods and casters. The top block contains the fluid inlet and
outlet ports. All dimensions are in millimeters.

The top block contains the inlet and outlet ports. A close-up view is shown in
Figure 2-13. A seal-tight ferrule/nut combination (F-290x/F-294x, Upchurch Scientific,
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Oak Harbor, WA) was screwed into the ferrule connector port, creating a watertight seal
and connecting tubing to the inlet and outlet ports. The ferrule is designed to fit tubing
with an outer diameter of 1/16 of an inch. The inlet/outlet ports have a diameter of 0.76
mm, and were designed to match tubing with an inner diameter of 0.030 inches.
The middle block was used as a cushioning/positioning block. Figure 2-13
shows a cross-sectional view of the top and middle blocks, with the planar
microfabricated electrode chip and the gasket pressed between the top and middle blocks.
The length of the space measured between the outer edge of the inlet port and the outer
edge of the outlet port was 6 mm, and this length was designed to fit over the entire MEA
3-electrode cell.
The dimensions of the gasket are shown in Figure 2-14. The gasket was designed
to be placed on top of the planar microfabricated chip with the 6.24 mm hole, located in
the center on the gasket, forming a chamber over the working, counter and reference
electrodes. The gasket had a length of 12.61 mm and a width of 11.67 mm. The reaction
chamber was made by punching a 6.24 mm hole through the silicon rubber. The chamber
hole was centered horizontally, and positioned vertically 2.33 mm from the top and 3.15
mm from the bottom. The clamp flow-though cell was used in combination with a 0.5
mm thick silicon gasket. The gasket forms a 15.3 μL volume chamber.
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Outlet port

Planar chip
with gasket
Figure 2-13: Magnified view of the flow-through detector cell displaying a crosssectional view of a planar electrode chip and gasket pressed between the top and middle
blocks. Solution enters and exits the chamber formed by the gasket through the inlet and
outlet ports. All dimensions are in millimeters.
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Figure 2-14: Clamp-style flow-through detector cell gasket for use with MEA chips.
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2.4.3

Microelectrode Array Cell Preparation
All three electrodes in the planar electrochemical cell were cleaned

electrochemically using CV before use. During electrochemical cleaning, the electrode
to be cleaned was used as the working electrode. An external silver wire and a platinum
coil electrode were used as reference and counter electrodes, respectively. The electrodes
were placed in a 0.2 M sulfuric acid solution, and the potential of the working electrode
was cycled between 0 and 1.2V at a scan rate of 300mV/s. Typically 10 scans were used.
Figure 2-15 displays CVs of a clean 2 μm MEA. The peaks displayed in the CV are from
the oxidation and reduction of gold.31 If the electrodes cannot be fully cleaned by
electrochemical means (i.e., extra peaks observed), the electrodes were cleaned in a RF
Plasma Cleaner/Sterilizer (Harrick Scientific Corp., Ossining, NY). A high RF (10-12
MHz) air plasma was applied to the chip at 300 mTorr for 3 minutes. The electrodes
were then rinsed with methanol and DI water. The small gold macroelectrodes located
on the MEA and IDA chips were modified to create Ag/AgCl reference electrode. The
gold macroelectrodes were electroplated with Ag/AgCl using Silver Cyless ® Conc and
0.1 M NaCl solutions using established protocols.8, 30, 38
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Figure 2-15: CVs of a clean 2 μm MEA in 0.2 M H2SO4 using a silver wire as reference
and a platinum coil electrode as counter.

2.4.4

Cleaning of the Gold Macroelectrodes in the Teflon Block Flow-Through
Detector Cell
First, the electrodes were polished with 600 and 1200 grit abrasive paper for 5

minutes each. Next, the electrodes were polished with 1.0, 0.3 and 0.05 micron alumina
paste for 5 minutes each. Finally, the electrodes were rinsed with methanol and DI water.
2.4.5

Chemicals and Reagents
Potassium hexacyanoferrate (III) trihydrate, 99% (K3Fe(CN)6 x 3H2O) and

ferrocenemethanol, 97% (FcMeOH) were purchased from Sigma-Aldrich (St. Louis,
MO).

Tetradodecylammonium chloride (TDDACl) was purchased from Fluka

Analytical (St. Louis, MO). Potassium tetrakis(pentaflouropheyl) borate (KTPFPhB) was
purchased from Boulder Scientific (Longmont, CO). Sodium tetrakis[(3,5bis(triflouromethyl)]phenylborate (NaTFPhB) was purchased from Dojindo Molecular
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Technologies Inc. (Rockville, Maryland). Tetradodecyammoniumtetrakis(pentaflourophenyl) borate (TDDA-TPFPhB) was produced by metathesis.44
Dichloromethane (≥99.5%) was purchased from Sigma-Aldrich (St. Louis, MO). 2nitrophenyl ocytl ether (o-NPOE) and high molecular weight polyvinyl chloride were
purchased from Fluka Analytical (St, Louis, MO). Silica Gel (GF-TLC) was purchased
from Selectro Scientific (Suwanee, GA). Fiberglass 9 Micron was purchased from
Corning Incorporated (Corning, NY). Tetrahydrofuran (Certified) was purchased from
Fisher Scientific (Pittsburgh, PA). 2,6-diisopropylphenol (97%), 4-Acetomido-phenol,
and L-ascorbic acid was purchased from Sigma-Aldrich (St. Louis, MO). A stock
solution of 10 mM DIPP + 0.1M NaOH was prepared and refrigerated until ready for use.
A 0.1 M PBS pH 7.2 solution (0.1 M sodium phosphate, dibasic + 0.1 M sodium
phosphate, monobasic +100 mM potassium chloride) was used as a background/carrier
solution. This will be known as Buffer 1. Buffer 2 contains the same formulation as
Buffer 1, only the KCl was eliminated. The composition of the background electrolyte
for voltammetric measurements and the carrier solution used in flow measurements was
the same. Solutions were sonicated for 5-10 minutes prior to use. All aqueous solutions
were prepared with deionzed (DI) water with a resistivity of 18 MΩ∙cm-1 obtained from
the Milli-Q Gradient A10 System (Millipore, Billerica, MA). Silver Cyless ® Con (6 TR
oz AG/gallon) was purchased from Technic Inc (Cranston, RI), and used to electroplate
silver onto the gold electrode for the preparation of the reference electrode. All other
chemicals were reagent grade and purchased from commercial sources.
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2.4.6

Preparation of Organic Electrolyte
Tetradodecyammonium-tetrakis(pentaflourophenyl) borate (TDDA-TPFPhB) was

produced by metathesis.44 A 1:1 molar ratio of KTPFPhB and TDDACl was dissolved in
dichloromethane (DCM). An equal amount of DI water was added to the solution. The
solution was gently agitated and allowed to stand for 1 hour. After an hour the aqueous
and organic portions of the mixture were visibly separated. The organic portion of the
mixture was decanted and the aqueous portion discarded. This separation was repeated
three times. The DCM was then evaporated under vacuum and the mass of the TDDATPFFPhB compound measured. The produced TDDA-TPFPhB was a viscous liquid with
a slightly yellow color. A yield of 96-98% was achieved. For easier handling, the
TDDA-TPFTPhB was dissolved in a small amount of DCM.
2.4.7

Organic Film Solution
The propofol measurements were performed with an organic film coated sensor.

The organic film was composed of 22% PVC, 44% o-NPOE, 22% TDDA-TPFPhB and
12% of either KTPFPhB or NaTFPhB. The o-NPOE was cleaned by forcing it through a
column of silica gel. Compacted fiberglass was used as a stopper to retain the silica gel
within the column. The film solution was created by dissolving the membrane
components in THF.
2.4.8

Film Deposition Protocol
The organic film was deposited onto the electrode chip surface by spin coating

using a membrane centrifuge. The MEA chips were held stable on the vacuum chuck of
the rotator column, located in the center of the membrane centrifuge. Approximately 100
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μL of the organic film solution was injected onto the chip surface, which was rotated at a
rate of 1000 RPM. The thickness of the deposited film depends on the rotation rate and
the concentration of the film solution. Two film thicknesses of approximately 1.7 μm
(59.5 mg PVC/119 mg o-NPOE/59.5 mg TDDA-TPFPhB/29.8 mg KTPFPhB /2.6 mL
THF) and 1.0 μm (32.0 mg PVC/64 mg o-NPOE/32.0 mg TDDA-TPFPhB/16.0 mg
KTPFPhB/1.9 mL THF) were deposited onto surface of electrodes. The thickness of the
films were determined with the Alpha Step 500 Surface Profiler (Tencor Corporation,
Milapitas, CA) using a stylus force of 1.4 mg and a scan speed of 2 μm/s. The film was
carefully sliced using a razor blade, and half of the film was removed from the glass chip.
The thickness of the film was determined by moving the stylus in a line from an area of
the chip with the film to an area in which the film had been removed. The thickness of
the film was determined by the height difference between the two sections. A film
thickness of 1.7±0.2 μm was calculated from 5 different chips. The film thickness of 1.0
μm was estimated experimentally from the rate of response of the membrane coated
sensors (Section 3.2.3).
2.4.9

Equipment and Setup
FlA experiments were performed with the FIA-AFAS. Unless otherwise

indicated, no mixing coil was used in the experiments. The distance between the sample
injection point and the flow-through detector cell ranged from 2 to 12.5 inches. CV and
CA measurements were performed using the FA-AFAS in continuously flowing or static
solutions. All Teflon connector tubing utilized in the AFAS had an inner diameter of
0.03 inches and an outer diameter of 1/16 of an inch. 2-stop Tygon tubing with an inner
diameter of 1.14 mm was used for the peristaltic pump. The flow rates from 54 to 580
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μL/min were used. In the literature flow rates can range between 1 and 3600 μL/min.3, 24,
35, 42, 51, 64, 72, 75, 77, 84, 93, 96

Offline beaker measurements were performed with the CHI 900

potentiostat (CH Instruments, Austin, TX).
2.4.10 Statistical Analysis
Statistical analysis was performed using One-Way and Two-Way ANOVA, t-test,
and the Grubbs‟ test. An alpha value of 0.05 was used for all statistical tests. Statistical
tables are shown in Appendix B.
2.5

Results and Discussion
To characterize the AFAS (i) the performance characteristics of the valves, (ii) the

reproducibility of repeated measurements, (iii) the feasibility of the utilization of CA and
CV techniques, and (iv) the feasibility of utilizing different flow operational schemes
(Section 2.2), were evaluated.
2.5.1

Characterization of the FIA-AFAS

2.5.1.1 6-PD Valve vs. 6-PL Valve: Injector Valve Performance Characteristics
In Section 2.1 the 6-PL and 6-PD valves were described. In the literature, almost
exclusively, loop valves are used in FIA experiments. However, time-based injections
using the 6-PD valve offers greater flexibility in designing FIA experiments. In this
section the characteristics of the 6-PL and 6-PD valves are compared as injector valves in
combination with the FIA-AFAS and the Teflon block flow-through detector cell. In
these experiments, a sample plug volume of 54 μL was injected in the carrier stream.
The flow rate of the carrier stream was 108 μL/min. For the 6-PL valve, the length of the
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sample loop was 4.66 inches (ID: 0.03 inches). For the 6-PD valve, a flow rate of 108
μL/min and an injection time of 30 seconds were used to inject the 54 μL volume sample.
The 54 μL time-injected volume was verified by measuring the mass of DI water pumped
for 30 seconds at 108 μL/min.
Figure 2-16a shows i-t transients recorded in the FIA experiments using the 6-PD
and 6-PL valves. The flow scheme shown in Figure 2-3 was used in combination with
the 6-PL valve. Figure 2-4 shows the flow scheme used in combination with the 6-PD
valve. The tubing between the injector valve and the detector was 7.3 inches. 10 mM
K3Fe(CN)6 was used as the sample solution, and the CA transients were recorded at a
potential of 0.5 V vs. Ag/AgCl. Unless otherwise stated, this potential is used in all the
experiments described below. In the case of each valve, four sample injections were
made during the period of the experiment. The experiment was repeated 5 times for each
valve, resulting in a total of 20 injections per valve.
A differential peak height (DPH) is calculated for each of the injections. The
value of the background current that was measured 5 seconds before the injection was
subtracted from the peak current value (i.e., current at Cmax). Figure 2-16b displays the
DPH for each injection. The Grubbs‟ test for statistical outliers was performed on each of
the data sets. One value in the 6-PD data set (circled in Figure 2-16b) was designated as
a statistical outlier. This value was removed from the statistical analysis. There is
significant overlap in the DPH values for each valve. The 6-PD and the 6-PL have an
average DPH of 1.58±0.07 and 1.62 x1±0.09 μA, respectively. The relative standard
deviation (RSD) of the DPH for the 6-PD is 4.3% (n=19). The DPHs for the 6-PL valve
had a RSD of 5.4% (n=20). A t-TEST value of t(37)=-0.28, p = 0.77 (Table 8-1/Figure
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8-1) allows the acceptance of the null hypothesis that there is no difference between the
mean DPH values of the two valves. The method of sample injection does not seem to
significantly affect the dispersion profile of the injected plug. Therefore, the 6-PD valve
can be used as an injector valve, and the 6-PL offers no significant advantage in
performance over the 6-PD valve.
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Figure 2-16: (a) Current-time transients recorded in a FIA experiment upon 4
consecutive injections of 54 μL volume of 10 mM K3Fe(CN)6. Carrier Electrolyte: Buffer
1. Flow Rate: 108 μL/min. Teflon flow-through detector cell. Applied potential: 0.5V
vs. Ag/AgCl. (b) DPH values following 20 injections performed with both the 6-PL and
6-PD valves.

2.5.1.2 6-PD Valve Performance for Sample Injections between 2 and 54 μL Volumes
To determine the volume range in which the 6-PD valve may be used as an
injector valve, the reproducibility of FIA transients were evaluated by injecting sample
volumes between 2 and 54 μL. The injection protocol was the same as shown Figure 216a. The i-t transients are shown in Figure 2-17a. Figure 2-17b displays the average
DPHs for each time-injected volume with standard deviations (n=20). Using the flow
rate of 108 μL/min, the approximate analysis time for a single sample was two minutes.
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Figure 2-17: (a) Current-time transients recorded in a FIA experiment upon 4
consecutive injections of 100 μM K3(Fe(CN)6). Injected Volumes: 2, 5, 13, 27 and 54
μL. 6-PD valve. Carrier Solution: Buffer 1. Teflon block flow-through detector cell.
Applied potential: 0.5V vs. Ag/AgCl. (b) Average DPHs ±1SD (n=20) vs. the injected
volume.

Table 2-1 displays the average DPH and the RSD (n=20) for each of the timeinjected volumes. Single outliers in the 2 and 27 μL data sets were removed. Data from
54 μL time-injected volume transients are shown in Table 2-2. The average DPH (n=4)
and SD are calculated from the 4 injection peaks in each transient. Using ANOVA, the
SD values shown in the last column of Table 2-2 were compared to the SD values
calculated from the DPHs of the other time-injection volumes (2, 5, 13, and 27 μL not
shown). No significant difference was found between the SD values for each of the data
sets, F(4,20)=1.62, p=0.21. This means that a constant „noise‟ signal (i.e., standard
deviation) is detected in all of the measurements, but the effect of the „noise‟ isn‟t as
noticeable for the larger time-injected volumes. This is reflected in the SD and RSD
values shown in Table 2-1.
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Table 2-1: Average DPH of the current-time transients recorded in the FIA experiments
with (± 1SD) and RSD (n=20) values for time-injected volumes ranging between 2 and
54 μL. *Data sets displaying single outliers (n=19).
Time-Injected Volume
(μL)
2
5
13
27
54

Average DPH (Amperes)
n=20
(0.9±0.2) x 10-7*
(1.9±0.2) x 10-7
(2.6±0.2) x 10-7
(3.8±0.2) x 10-7*
(4.3±0.1) x 10-7

RSD
20.6%
12.1%
5.6%
4.9%
3.2%

Table 2-2: DPH values, their means and standard deviations from the i-t transients
following the injections of 54 μL volume samples using time-injected volume.

Transient 1
Transient 2
Transient 3
Transient 4
Transient 5

DPH 1
(A)
4.6 x10-7
4.5 x10-7
4.3 x10-7
4.4 x10-7
4.4 x10-7

DPH 2
(A)
4.4 x10-7
4.4 x10-7
4.2 x10-7
4.2 x10-7
4.2 x10-7

DPH 3
(A)
4.3 x10-7
4.3 x10-7
4.2 x10-7
4.2 x10-7
4.1 x10-7

DPH 4
(A)
4.4 x10-7
4.3 x10-7
4.5 x10-7
4.2 x10-7
4.1 x10-7

Mean
n=4
4.4 x10-7
4.4 x10-7
4.3 x10-7
4.3 x10-7
4.2 x10-7

SD
n=4
0.1 x10-7
0.1 x10-7
0.2 x10-7
0.8 x10-8
0.2 x10-7

Inserting a mixing coil between the injector and the detector has been shown to
improve the reproducibility of measurements.53, 69 A mixing coil with an inner diameter
of 0.03 inches and a length of 12.5 inches was inserted between the 6-PD valve and the
flow-through detector cell. The time-based injection experiment was repeated using the
same injected volumes and flow rate. Because of its large RSD in the previous
experiment, the 2 μL time-injected measurement was removed.
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Figure 2-18: (a) Current-time transients recorded in a FIA experiment upon 4
consecutive injection of 100 μM K3Fe(CN)6 using the and a 12.5 inches long mixing coil
was placed between the injector and the detector cell. Injected Volumes: 5, 13, 27 and 54
μL. Carrier Solution: Buffer 1. Flow Rate: 108 μL/min. Teflon block flow-through
detector cell. Applied potential: 0.5 V vs. Ag/AgCl. (b) Average DPHs ± 1SD (n=20) vs.
the injected volume.

The i-t transients recorded with a 12.5" long mixing coil are shown in Figure 218a. With the mixing coil, the distance between the valve and the flow-through detector
cell was increased. This results in a greater dispersion of the sample zone. The time it
takes for the sample to reach the flow-through cell was also increased. Using a flow rate
of 108 μL/min, the analysis time for a single injection was approximately 4 minutes. The
transients displayed in Figure 2-18a are noticeably broader, while the peak heights are
smaller when compared to Figure 2-17a. Figure 2-18b displays the average DPHs (n=20)
with respect to the time-injected volume. There is approximately a 14% decrease in the
signal amplitude when compared to Figure 2-17b.
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Table 2-3: Average DPH of the current-time transients recorded in the FIA experiments
with (± 1SD) and the RSD (n=20) values for time-injected volume between 5 and 54 μL
using mixing coil. *Data sets displaying single outliers (n=19).
Time-Injected Volume
(μL)
5
13
27
54

Average DPH (Amperes)
n=20
(5.2±0.3) x10-8*
(9.6±0.3) x10-8
(1.6±0.6) x10-8
(2.4±0.1) x10-7

RSD
5.7%
3.3%
4.0%
4.7%

Comparing the SD values seen in Tables 2-1 and 2-3, the mixing coil decreased
the SD values, on average, by a factor of three. Consequently, the RSD values were
decreased, on average, by a factor two. The improvement in the SD of the DPH values is
statistically significant, (p=7x10-5). This suggests that a mixing coil improves the
reproducibility of the measurement across time-injected volumes.
In summary, it was found that the 6-PD can be used as a time-based injector
valve, and the reproducibility of the injection is similar to that of 6-PL valve. Unlike the
6-PL valve, the 6-PD valve can be easily configured to inject a wide range of sample
volumes. In general, the mixing coil improves the reproducibility of the measurement.
The improvement was especially significant for small time-injected volumes. However,
the use of the mixing coil increased the analysis time, e.g., reduces the number of
injection per minute.
2.5.1.3 Performance of the Response Characteristics of the FIA-AFAS using
Calibration Standards
In FIA the concentration of an unknown sample is derived from a calibration
curve which has been recorded in the same manifold under the same experimental
conditions, (injected volume, flow rate, etc.) using standard solutions. The precision and
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accuracy of the results depend on the reproducibility of the measured quantity (e.g., DPH,
area of the transient curve, etc.) in repeated measurements and the quality of the
calibration curve. The quality of the calibration curve can be characterized by the
residual mean standard deviation (RMSD) of the individual points around the fitted line.
To demonstrate the performance characteristics of the FIA-AFAS for
determination of unknown samples, FIA calibration curves were recorded by injecting
FcMeOH of different concentrations (1 to 100 μM) into the carrier stream. In these
experiments the 6-PD valve was used to inject a 27 μL volume sample plugs into the
carrier stream.
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Figure 2-19: (a) Current-time transients recorded following consecutive injections in a
FIA experiment with 27 μL injection volume. Injected Sample Concentrations: 1, 5, 10,
50, and 100 μM FcMeOH. Carrier Solution: Buffer 1. Clamp-style flow-through
detector cell. Applied potential: 0.5 V vs. Ag/AgCl. (b) First 500 seconds of the
current-time recording displaying 3 injection of the 1 μM FcMeOH sample. (c)
Calibration curve generated using the average DPHs and a fitted line determined by leastsquares regression.
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Figure 2-19a displays i-t transients recorded during the calibration measurement.
Each analyte is injected three times. The entire experiment was repeated twice. Figure
2-19b shows the i-t transient following the injections of 1 μM FcMeOH. Figure 2-19c
displays the average DPH±1SD (n=6) measured at different concentrations and a line
fitted to the calibration points by linear least-squares regression. As expected, the DPH is
directly proportional to the sample concentration. Table 2-4 displays the average DPHs
and their RSDs. The somewhat larger RSD at the 1 μM concentration may be related to
the incomplete decay of the residual current before the first measurement (Figure 2-19b).

Table 2-4: Average DPH of the current-time transients recorded in the FIA experiments
with (± 1SD) and the RSD (n=6) values for a 27 μL injected volume.
Concentration [μM]
1
5
10
50
100

2.5.2

DPH(Amperes)
(8.7±0.8) x10-10
(7.7±0.2) x10-9
(1.66±0.01) x10-8
(8.2±0.3) x10-8
(1.95±0.01) x10-7

RSD (n=6)
8.9%
2.1%
0.7%
3.9%
4.9%

Characterization of the FA-AFAS
Compared to the FIA-AFAS, The FA-AFAS provides a variety of measurement

possibilities. The following experiments demonstrate the FA-AFAS ability to: (i)
perform measurements in static and flowing solutions, (ii) perform concentration gradient
measurements, and (iii) perform repeated measurements over a long time period.
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2.5.2.1 Calibration Measurements Performed under Hydrodynamic Conditions
The FA-AFAS can be used to perform measurements under flowing conditions.
Six standard solutions from 1 to 100 μM FcMeOH were used. The flow-through detector
cell was filled with the standard, and an electrochemical measurement was performed in
the flowing standard solution. Both cyclic voltammetry (CV) and chronoamperometry
(CA) were used as the electrochemical technique. The i-E transients for the CV
experiments are shown in Figure 2-20a. The i-t transients for the CA experiments are
shown in Figure 2-20b.
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Figure 2-20: (a) Cyclic voltammetry and (b) chronoamperometric transients recorded in
flowing sample solutions with the 10 μm MEA chip. Sample Concentrations: 1, 5, 10,
50, and100 μM FcMeOH. CVs applied at a scan rate of 100 mV/s. CA i-t transients
recorded at a potential of 0.45 V vs. Ag/AgCl for 60 seconds. Background Electrolyte:
Buffer 1. Clamp-style flow-through detector cell. Flow Rate: 54 μL/min.
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Figure 2-21 shows two calibration curves constructed from the limiting currents
in Figure 2-20a and the steady-state currents in Figure 2-20b. Using linear least-squares
regression, Equations 6 and 7 were derived from data in Figure 2-21.

iCV  0.433C 0

(6)

iCA  0.433C 0

(7)

The RMSD values for fitted lines representing the calibration cures recorded in
the CV and CA experiments are 6.7x10-10 and 2.8x10-10A, respectively. Detection limits
(DL=3xRMSD/slope) are 5±2 μM and 2.0±0.7 μM for CV and CA experiments,
respectively. As expected, the CA technique had a somewhat better DL compared to the
CV measurements.
Using Equations 5 (Section 2.4.1) and the values D=7.2x10-6 cm2/s for FcMeOH
11

, r=5x10-4 cm, and l=1.5x10-4 cm, the number of individual microdisk electrodes in on

the 10 μm MEA was calculated as N= 390±19. The number of microdisks estimated
from the microdisk patterned area of the MEA is 359±5. This number was calculated
based on the number of individual microdisk that could fit on the 3 mm diameter MEA
surface. There is an 8.3% percent difference between the N derived electrochemically
and the N calculated from the physical area. Inaccuracies in the diffusion coefficient and
the specified r or l values may account for the difference.
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Figure 2-21: Steady state and limiting current values plotted vs. concentration from the
CV and CA transients recorded in solutions flowing at a rate of 54 μL/min. The figure
has been constructed from data in Figure 2-20.

In these experiments the FA-AFAS successfully utilized two electroanalytical
techniques in flowing solutions. Detection limits consistent with the applied
electroanalytical techniques were achieved.
2.5.2.2 Measurement of Sample Dispersion with the FA-AFAS in Stopped Flow
The FA-AFAS can be used to measure a specific region of a dispersed injected
sample if: (a) the flow of solution is stopped, and (b) the volume of the injected sample is
greater than the flow-through detector cell volume. An example of a dispersed sample
plug is shown in Figure 2-22b. At t0 (t=0) the plug is injected into the carrier solution,
and the plug has a homogenous concentration profile in the tubular flow path (Figure 222a). At tn the dispersed sample plug has passed completely through the flow-through
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detector cell, and a background current would be measured by the detector. Each region
between t0 and tn, regions „1‟ to „11‟, corresponds to: (i) a concentration in the dispersed
sample plug, and (b) a time in which that region comes in contact with the detector. For
example, the detector will encounter the region at time „1‟ before the region at „2‟. If the
flow of solution is stopped at time points „1‟ through „11‟ and voltammetric
measurements are performed in the stopped solutions, the measured currents will
represent the concentrations of the dispersed sample at the selected time points. For
example, if the flow of solution is stopped at region „4‟ the measured current would be
proportional to Cmax. From these data, it is possible to construct the concentration profile
of the dispersed sample of a FIA experiment.
The FA-AFAS has been used to construct a FIA transient, following the injection
of a 54 μL volume sample of 100 μM FcMeOH, from individual measurements
performed in consecutive segments of the injected plug. The dispersed sample plug was
separated into 17 regions. Each region corresponded to a 2 second advancement of the
dispersed sample plug within the flow though detector cell. At t=0 seconds the sample
plug is injected into a carrier stream. Four seconds (t = 4 s) after the injection, the flow
was stopped, and a CV was applied at a scan rate of 100 mV/s. The plug was then
advanced 2 seconds (t = 6 s) and another measurement was performed. This step-by-step
procedure was repeated in 2 second intervals until t = 38 seconds after the injection.
Figure 2-23 displays the overlaid CVs for measurements recorded in regions t=4 to t=38
seconds. The amplitude of the peak currents are gradually increasing (Figure 2-23a) in
the first phase of the FIA experiment until the concentration reaches Cmax. Figure 2-23b
displays CVs with gradually decreasing peak current values corresponding to the second
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phase of the experiment, when the plug is washed out of the cell, i.e., Cmax decays to C =
0. At time t = 38 s the analyte plug has completely cleared the flow-through detector cell.
This experiment was repeated 5 times.

a.

b.

Figure 2-22: (a) Initial sample plug as it is injected into the tubular flow path. (b)
Dispersion profile of an injected sample plug. The 11 time points labeled on the time
axis correspond to 11 concentration regions of the dispersed sample. Time interval t=4
corresponds to Cmax. Taken from Reference 70.
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Figure 2-23: Overlaid CV transients recorded in 17 segments of a single 54 μL volume.
(a) CV transients recorded in the first phase of a FIA transient, from t=4 s until the
concentration in the cell reaches Cmax. (b) CV transients recorded in the second phase of
the FIA transient, from t=20 s until the dispersed sample has cleared the flow-through
detector cell. Scan Rate: 100 mV/s. Injected sample concentration: 100 μM FcMeOH.
Working Electrode: 2 μm MEA. Carrier Solution: Buffer 2. Clamp-style flow-through
detector cell. 6-PL valve. Flow Rate: 540 μL/min.

Figure 2-24 displays an i-t transient constructed from the peak currents of the CVs
in Figure 2-23. The error bars show the SD across five experiments. The shape of the
constructed i-t transient is representative of the concentration profile of the injected
sample plug.
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Figure 2-24 Flow injection transient constructed from the peak current values in Figure 223. Inserts: Selected CVs from Figure 2-23 corresponding to time points at t=10, 14, and
20 s.

The above experiment was also completed for FcMeOH concentrations of 20 to
80 μM. Because the 6-PL valve was used, the sample concentrations were switched
manually. Table 2-5 displays the peak current values at Cmax for each concentration. In
total, twenty-five 54 μL plugs (5 for each concentration) from 20 to 100 μM FcMeOH
were measured. The RSD values in the last column of Table 2-5. The reproducibility of
the measurements is consistent with previous FIA results (Table 2-3).
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Table 2-5 Peak currents, mean, and RSD (n=5) of the CV transients at the time region of
Cmax for twenty-five 54 μL volume plugs of 20 to 100 μM FcMeOH.
FcMeOH
[μM]
100
80
60
40
20

Cycle 1
(A)
2.54x10-7
2.20x10-7
1.53x10-7
1.01x10-7
5.13x10-8

Cycle 2
(A)
2.52x10-7
2.18x10-7
1.48x10-7
9.79x10-8
5.22x10-8

Cycle 3
(A)
2.54x10-7
2.15x10-7
1.49x10-7
9.97x10-8
5.17x10-8

Cycle 4
(A)
2.54x10-7
2.09x10-7
1.50x10-7
9.63x10-8
5.14x10-8

Cycle 5
(A)
2.53x10-7
2.08x10-7
1.51x10-7
9.37x10-8
5.14x10-8

Mean
n=5
2.53x10-7
2.14x10-7
1.50x10-7
9.78x10-8
5.16x10-8

RSD
0.4%
2.5%
1.2%
3.1%
0.7%

The average peak current values from Table 2-5 are plotted versus the sample
FcMeOH concentration in Figure 2-25. Using linear least-squares regression, a slope of
2.6x10-9 A/μM was derived from data in Figure 2-25. The detection limit was calculated
as 7±2 μM (DL=3xRMSD/slope). These results are consistent with previous
measurements (Section 2.5.2.1)
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Figure 2-25: Calibration curve plotting the average peak current values in Table 2-5
versus the injected sample concentration. Line fitted to the data points using linear leastsquares regression.
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2.5.3

Long-term Monitoring Experiments with the FA-AFAS
Ferrocenemethanol was used as a model compound to demonstrate the

performance of the AFAS in long-term continuous monitoring experiments. In this
protocol a 54 μL volume samples were analyzed every five minutes for 6 hours.
The 2 μm IDA was used as the working electrode, with both sides of the IDA
interconnected. The interconnected electrodes have to same electrochemical properties
as a macroelectrode. The total distance between the injector and flow-through detector
cell included a 12.5 inch mixing coil and 2 inches of connecting tubing. In the course of
the monitoring experiment, five standard solutions of 1 to 80 μM FcMeOH were used as
samples. Sample plugs were moved into the flow-through detector cell and stopped at
the time interval corresponding to Cmax. A CA measurement was then performed by
applying 0.4 V vs. Ag/AgCl for 60 seconds.
Figure 2-26a shows the chronoamperometric i-t transients recorded in 5 minute
intervals in 0, 20, 40, 60, and 80 μM FcMeOH solutions. The total procedure time was
36 minutes. To construct a calibration curve, background subtracted values taken at t=58
seconds of the i-t transients were plotted against the concentration (Figure 2-26b).
Utilizing the cycle control, described in Section 2.1, the experiment was repeated 10
times, producing 10 calibration curves, and resulting in a total experimental time of 6
hours. The slopes of the calibration curves were determined by linear least-squares
regression. Across the 10 experimental cycles, the average slope value of the calibration
curves was 0.040±0.002 (A cm3/mole). The RSD (n=10) of the slope values was 4.2%.
An average detection limit of 5±2 μM for the data taken at t=58 seconds was calculated
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using 3xRMSD/slope. The calculated detection limit was consistent with the
electrochemical technique.
Overall, the results discussed above show that the FA-AFAS is adequate to
perform long-term, repeated measurements with small sample volumes.
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Figure 2-26: (a) Cycle 1 chronoamperometric i-t transients performed in 54 μL samples
stopped at Cmax. One sample is measured every five minutes. Sample Concentrations: 0,
20, 40, 60, and 80 μM FcMeOH. Carrier Solution: Buffer 1. Flow Rate: 324 μL/min.
Clamp-style flow-through detector cell. Applied Potential: 0.4 V vs. Ag/AgCl for 60
seconds. (b) Current values at t=58 seconds of the transients in Figure 2-26a. vs. the
injected sample concentration. Fitted curve calculated by linear least-squares regression.

To determine whether the analysis time can be shortened without compromising
the reproducibility and detection limit of the measurements, calibration curves were also
constructed and analyzed using the current values measured at t= 0.5, 1, 2, 5, 10, and 20s.
The results are summarized in Figure 2-27. The slope values (A cm3/mole) are plotted on
the left Y-axis. The detection limits (moles/L) are plotted on the right Y-axis. On the Xaxis the points used for evaluation of the slopes and DLs are labeled. As expected, the
amplitude of the slope values change depending on the time „t‟ in which the values were
taken from the i-t transient. From the Cottrell equation (Equation 3), it is known that the
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measured signal decays with the inverse square-root of time. Ten detection limit values
were calculated for each time category (Table 8-2). The average of the detection limits
(n=10) are shown in Figure 2-27 for each time category. Using ANOVA, it was
determined that there is no significant difference between detection limits calculated at
the various times, F(6,63)=0.46, p=0.84 (Figure 8-2). This can be explained by the data
in Figure 2-27 and Table 2-6. As the time increases, there is a decrease in the sensitivity
(i.e., slope) and the standard deviation of the measurement. From the data, it is clear that
shorter measurement times could possibly be used. However, the shorter measurement
times have a larger SD in the measured signal.
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Figure 2-27: Slopes of the calibration curves and the detection limits for t= 0.5, 1, 2, 5,
10, 20, and 58 s. Left Y-axis: Slope values (A cm3/mole). Right Y-axis: Detection
limits calculated from the RMSD and the slope (moles/L). X-axis: time value of the
measured data. The graph show the percent deviation in the calculated slopes of the
calibration curve and the calculated detection limits for the different time „t‟.

Table 2-6: SD and RSD values of the slopes (S) in Figure 2-27
Time
(seconds)
0.5
1.0
2.0
5.0
10.0
20.0
58

SD of S (A cm3/mole)
n=10
1.2E-02
7.1E-03
5.5E-03
4.0E-03
3.9E-03
2.7E-03
1.7E-03
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RSD of S
(n=10)
5.6%
5.2%
5.6%
5.7%
5.5%
5.1%
4.2%

2.5.4

Day-to-Day Reproducibility of Measurements using Planar MEA Electrodes
Propofol sedation can range from hours to days. It was of interest to determine

the performance of the microfabricated electrode over several days of use. The
experiment described in Section 2.5.3 was repeated three times over the course of one
week. Between experiments, the electrode remained within the flow-through detector
cell filled with DI water. Unless otherwise indicated, the protocol was the same as
described in Section 2.5.3.
The FA-AFAS was used in combination with the 6-PL. The 6-PL valve was used
to inject a 69 μL sample plug into a carrier stream of Buffer 2 solution. The carrier stream
was pumped at a flow rate of 540 μL/min. The clamp-style flow through cell was used in
combination with the 0.5 mm silicon gasket and a 2 μm MEA chip. Five standard
solutions with concentrations between 1 to 80 μM FcMeOH were used. The current
readings at t=58 seconds of the i-t transients were used to construct calibration curves.
Table 2-7 summarizes the results of the experiment. Statistical outliers were
identified by the Grubbs‟ test. Within each day, a RSD value of less than 2% was seen
without outliers. When outliers are included, the RSD values were less than or equal to
3.2%. The improved RSD values are attributed to the increased sample plug volume.
Over all of the experiments, the RSD values were less than 4.2%.
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Table 2-7: Average slope values (S) of calibration curves and the RSD with and without
statistical outliers.

Day 1
Day 4
Day 7
All

S without
outliers (A/M)
(n=9)
4.6 x10-4
4.9 x10-4
4.9 x10-4
4.8 x10-4

S with outliers
(A/M) (n=10)

RSD without
outliers (n=10)

RSD with
outliers (n=9)

4.6 x10-4
5.0 x10-4
5.0 x10-4
4.8 x10-4

1.7%
1.5%
1.8%
3.9%

2.8%
2.3%
3.2%
4.2%

An ANOVA of the slope values (Table 8-3) from the 3 data sets (i.e., Day 1, Day
4, and Day 7) showed a significant difference between the data sets, F(2,24)=57.3,
p<0.001 (Figure 8-3). However, no significant difference was found between the Day 4
and the Day 7 data sets, t(16)=0.45, p=0.66 (Figure 8-4). This box-plot in Figure 2-28 is
a graphical representation of the data shown in Table 2-7. The statistical outliers were
excluded. In agreement with the statistical analysis, it shows that Day 4 and Day 7 data
sets have a similar range and median value, as opposed to the Day 1 data set.
Despite the statistically significant difference in the slopes of the calibration
curves recorded at Days 1, 4, and 7, there is only a 4.2% RSD between all the data sets.
The difference in the slopes is probably caused by changes in the electrode over time. In
extended experiments, periodic calibration can be used to compensate for these changes.
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Figure 2-28: Box-plot of the slope data (S) from Table 2-7. Statistical outliers are
excluded.

2.6

Conclusion
The purpose of the experiments summarized in Chapter 2 was to demonstrate the

capability of the AFAS as an automated flow analytical system though selected
examples. Measurements were performed using various experimental conditions
including a wide range of sample volumes, and sample concentrations. The experiments
utilized two flow through-detector cells and a variety of electrode configurations.
Through examples, it has been shown that the AFAS is able to implement a FIA
experiment using either the 6-PL or the 6-PD valve. The AFAS is also able to perform
stopped flow CA or CV measurements Calibration experiments can be completed using
small volume injected samples or under continuous sample flow. The experiments also
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demonstrate the AFAS‟s ability to apply two electrochemical techniques,
chronoamperometry and cyclic voltammetry, and to achieve detection limits consistent
with these techniques. The AFAS can be used to implement a continuous monitoring
protocol over extended time periods.
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3

CHARACTERIZATION OF THIN POLYMERIC FILM MODIFIED
ELECTRODES IN THE FIA-AFAS
To determine if the AFAS can be used in combination with an organic film coated

sensor, ferrocenemethanol was used a model compound. The differences between a
membrane modified and an unmodified electrode has been studied. In these studies we
compared the: (i) response time of the working electrode, (ii) steady-state current value
for a given sample concentration, (iii) the analysis time (i.e., time from injection for the
sample to completely clear the flow-through detector cell), (iv) detection limit, and (v)
reproducibility of the of the measurements using a membrane modified electrode and a
bare electrode.
3.1

Theory
The response of the membrane modified electrode is affected by the mass transport

in the solution and in the membrane and the rate of electron transfer between the analyte
and the electrode. When the membrane coated electrode is placed into the aqueous
solution, FcMeOH partitions between the aqueous sample and the membrane. As shown
in Figure 3-1a, at equilibrium the concentrations are constant and independent of the
distance from the electrode. C0 is the sample concentration. CS is the concentration at the
film/aqueous interface. CM is the membrane concentration. δ is the thickness of the film.
CE is the electrode surface concentration. x is the distance from the surface of the
electrode. The membrane concentration can be calculated from the partition coefficient
(Equation 8):
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C M  C S

(8)

where κ is the partition coefficient. At equilibrium the membrane surface concentration
(CS) and the sample concentration (C0) are equal.

a.

Film

Solution

CE

Cs

Electrode

C0

Stirred

CM=κCS

0

δ

0

x→

CE

b.

C0

00

CM=κCS

Stirred

Electrode

Cs

δ

Φ

x→

Figure 3-1: Schematic of the concentration profiles of a membrane coated electrode at
(a) equilibrium and at (b) steady-state after application of an adequate potential. The
distances are not shown to scale. Reproduced and modified from Marrese et al., Bard et
al., and Leddy et al.2, 50, 59
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After application of an adequate potential, the electrode surface concentration of
FcMeOH drops to zero. At steady state, the flux in the membrane is equal with the flux
through the aqueous solution layer. The concentration profiles at steady state in the
membrane and the adjoining aqueous layer are shown in Figure 3-1b. At steady-state the
flux of FcMeOH in the film is represented by Equation 9:

J Film 

D M C M  0





DM C M

(9)



where JFilm is the flux in the film. DM is the diffusion coefficient within the film. The
flux of FcMeOH in the aqueous solution is represented by Equation 10:

J Aqueous 



DS C 0  C S




(10)

where JAqueous is the flux in the aqueous solution. Φ is the thickness of the diffusion layer
outside of the film. DS is the diffusion coefficient of the FcMeOH in aqueous solution.
The thickness of the diffusion layer under laminar flow is in the micrometer range.52
This is the same order of magnitude as the thickness of the membrane. The diffusion
coefficient of FcMeOH in the aqueous phase is 10-5 cm2/s. While the diffusion
coefficient for FcMeOH in the membrane is approximately 10-8 cm2/s. This value is
based on diffusion coefficient measurements in ISE membranes.48, 71 Consequently, for
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Equations 9 and 10 to be equal, the concentration polarization in the aqueous solution
layer must be much smaller than in the membrane. In agreement with this statement, the
amperometric current of a membrane coated electrode is barely influenced by the rotation
rate.43
3.2
3.2.1

Results and Discussion
Flow Injection Analysis with a Polymeric Membrane Coated Electrode
The influence of a thin polymeric membrane, coated on the surface of the working

electrode, has been evaluated. In these studies, the 6-PD valve was used in combination
with the FIA-AFAS to make timed-injected volumes ranging from 27 to 360 μL.
FcMeOH concentrations from 5 to 80 μM were used as the injected samples. The carrier
solutions was flowed for 30 seconds before samples injections were made. The flowthrough detector cell was located 5.8 inches from the injector. These measurements were
completed with both an unmodified and a 1.0 μm thick membrane modified 2 μm MEA
chip.
Figures 3-2a and 3-2c display the overlaid i-t transients following the injection of
different volumes of 5 μM FcMeOH concentration. The dispersion of the sample plug is
described by Equation 4 (Section 2.1). As the injected volume increases there is an
increase in the peak height of the transients. If the injected sample volume is larger than
180 μL, Cmax becomes equal to C0 and the i-t transients reach a steady-state. This is
shown in Figures 3-2b and 3-2d, where the DPHs of the i-t transients are plotted versus
the time-injected volume. Figures 3-2a and 3-2c appear very similar, but the amplitude
of the signals is smaller with the membrane coated sensors.
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Figure 3-2: Overlaid FIA i-t transients of 27, 45, 64, 90, 180, 360 μL injection volumes
of 5 μM FcMeOH with (a) an unmodified and (c) a 1.0 μm thick membrane modified 2
μm MEA electrode. Carrier Solution: Buffer 2. Flow Rate: 540 μL/min. Clamp-style
flow through detector cell. 6-PD valve. Applied Potential: 0.5 V. DPHs from the i-t
transients for different time-injected volumes of 5, 20, 40, 60 and 80 μM FcMeOH
solutions for the (b) unmodified and (d) 1.0 μm thick membrane modified 2 μm MEA
electrode.

The RSD of the DPH values for the unmodified and the 1.0 μm thick membrane
modified electrode are summarized in Tables 3-1 and 3-2, respectively.
Two-way ANOVA was used to test if the SDs of the DPHs for the unmodified
electrode (Table 8-4) were influenced by either the concentration or the volume of the
injected sample. A F(4,16)=1.3, p=0.31 (Figure 8-5) allows the acceptance of the null
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hypothesis that there is no significant difference in the SD of the DPHs with respect to
injected volume. A F(4, 16)=1.8, p=0.16 (Figure 8-5) allows acceptance of the null
hypothesis that there is no significant difference in the SD of the DPHs with respect to
concentration. This translates into larger RSDs following the injection of dilute samples
and small injected volumes.
A two-way ANOVA was also performed on the 1.0 μm thick membrane
modified electrode FIA results (Table 8-5). A F(5,20)=1.0, p=0.5 (Figure 8-6) allows the
acceptance of the null hypothesis that there is no significant difference in the SD values
based on injected volume. A F(4, 20)=1.5, p=0.23 (Figure 8-6) allows acceptance of the
null hypothesis that there is no significant difference in the SD values based on
concentration.

Table 3-1: The RSD (n=5) of the DPHs recorded with an unmodified electrode in FIA
experiments. Injections were made with of different sample volumes and concentrations.
‡No data.
Injected Volume (μL)
5 μM
20 μM
40 μM
60 μM
80 μM
27
45
64
90
180
360

4.9%
0.6%
1.9%
0.5%
0.8%
0.3%

1.1%
1.1%
‡
0.6%
0.1%
0.5%
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2.3%
1.5%
0.7%
0.6%
0.4%
0.1%

0.8%
0.4%
0.8%
0.5%
0.2%
0.1%

0.1%
0.1%
0.6%
0.8%
0.4%
0.2%

Table 3-2: The RSD (n=5) of the DPHs recorded with an 1.0 μm thick membrane
modified electrode in FIA experiments. Injections were made with of different sample
volumes and concentrations.
Injected Volume (μL)
5 μM
20 μM
40 μM
60 μM
80 μM
27
12.6%
1.9%
2.7%
3.4%
0.3%
45
11.2%
0.5%
1.6%
0.2%
0.0%
64
2.0%
0.3%
1.4%
0.6%
0.5%
90
1.0%
1.0%
0.0%
1.0%
0.4%
180
0.6%
0.0%
0.3%
0.2%
0.4%
360
3.2%
0.3%
0.8%
0.1%
1.0%

In Figure 3-3 the DPH of the i-t transients are plotted as a function of the
concentration. The figure is a alternative representation of the data shown in Figure 3-2b.
It demonstrates the linear response of a voltammetric sensor. The larger time-injected
volumes provide a higher sensitivity than the smaller volumes. This same trend was
found with the membrane modified electrode.
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Figure 3-3: DPHs plotted versus the concentration of the injected sample for injected
volumes of 27, 45, 64, 90, 180, and 360 μL for an unmodified electrode.

Figure 3-4 shows the average DPH versus the injected volume for a 1.7 μm thick
membrane modified electrode. The DPH of the signals were approximately 1.7 times
smaller than the DPHs recorded with a 1.0 μm thick membrane modified electrode.
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Figure 3-4 : DPH values of the i-t transients recorded following injections of 5, 20, 50,
60, and 80 μM FcMeOH solutions. Injected Volumes: 27, 45, 64, 90, 180, 360 μL.
Electrode: 1.7 μm membrane modified electrode. Carrier Solution: Buffer 2. Flow Rate:
540 μL/min. Clamp-style flow through detector cell. 6-PD valve.

It was of interest to determine if the thickness of the membrane had any affect on
the analysis time. Figure 3-5 displays three i-t transients following the injection of a 27
μL volume of 80 μM FcMeOH. The three curves were recorded with an unmodified, a
1.0 μm thick membrane modified electrode, and a 1.7 μm thick membrane modified
electrode. The current recorded with the unmodified electrode decays back to its
background value after approximately 35 seconds, following the injection. For the
membrane modified electrodes, the analysis time was only slightly longer, approximately
45 seconds. From the 45 second analysis time, 35 seconds was attributed to the transport
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of the sample plug through the flow-through detector cell and the additional 10 seconds
was needed for the removal of FcMeOH from the film.
The peak heights of the FIA transients are affected by the thickness of the
deposited membrane. The unmodified electrode has the largest peak, while the 1.7 μm
thick membrane modified electrode has the smallest. The measured current is directly
proportional to the flux of FcMeOH to the electrode surface (Equation 9). The flux is
inversely proportional to the film thickness. Electrodes modified with a thicker film are
expected to have a smaller measured current.
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85
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Figure 3-5: Current-time transients recorded in FIA experiments following injection of
27 μL of 80 μM FcMeOH with an unmodified MEA electrode, a with MEAs coated with
1.0 and 1.7 μm thick membranes.

The influence of the membrane thickness on the sensitivity of the measurements
is also seen in Figure 3-6. The figure shows FIA calibration curves recorded with
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unmodified and membrane modified MEAs. The sensitivity is the highest with the
unmodified electrode. Linear least-squares regression was used to derive the slope values
of the calibration curves.
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Figure 3-6: Calibration curves constructed from the DPHs following the injections of
360 μL volume samples with different concentrations. The steady-state i-t transient
values (i.e., 360 μL injected sample volume) of a 2 μm MEA working electrode, without
coating and with 1.0 and 1.7 μm thick membrane coatings, were used.

The detection limits of the regression lines were calculated using
DL=3xBackground Current/Slope. The results are shown in Table 3-3. At a timeinjected volumes larger than 64 μL, the 1.0 μm modified electrode offers detection limits
similar to DLs reported for unmodified electrodes with common voltammetric techniques
(i.e., CA or CV).
Each of the above experiments required approximately 6 ½ hours to complete. If,
as in the continuous monitoring experiment described in Section 2.5.3, one sample is
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measured every 5 minutes for 6 ½ hours, for the 64 μL injected sample volumes, only a 5
mL of sample would be used. The utilization of ~5 mL of sample for a 6 ½ hours
monitoring experiment is acceptable.

Table 3-3: Detection limit of for the unmodified and modified electrodes across all
injected volumes. Detection limits calculated using DL=3xBackground Current/Slope
Unmodified
1.0 μm Film
Volume Injected (μL)
[μM]
[μM]
4
±
1
11
±
4
27
45
3±1
9± 3
64
2.4 ± 0.8
7 ±2
90
2.3 ± 0.8
6±2
180
2.1 ± 0.7
6±2
360
2.4 ± 0.8
5±2

3.2.2

Determination of the Diffusion Coefficient of FcMeOH within the Polymeric
Membrane and the Determination of the Membrane Thickness
The time dependent change in concentration on the electrode surface of a

membrane modified electrode is commonly described by Equation 11:

C S (t )  C 0  (C   C 0 )(1  e

t



)

(11)

where Cs(t) is the time dependent concentration on the sensing surface. C0 is the
concentration outside of the membrane before it is changed (t<0). C∞ is the concentration
outside the membrane after it is changed according to a step function (t≥0). τ is the time
constant.

82

In voltammetric analysis the current is directly proportional to the concentration;
Equation 11 can be rewritten as Equation 12:

i (t )  i 0  (i   i0 )(1  e

t



 i 0  (i   i 0 )  (i   i 0 ) e
 i   (i   i 0 ) e

t

)
t



(12)



where



2

(13)

2 DM

i(t) is the time dependent current. i0 is the current before the concentration change. i∞ is
current after the step change in concentration.  is the thickness of the membrane. DM is
the diffusion coefficient in the film. t is time in seconds. If the thickness of the


membrane coating is known, the diffusion coefficient of the analyte in the film can be
calculated by fitting Equation 12 to the i-t transients following a step change in
concentration. Figure 3-7 shows the i-t transients recorded with 1.0 and 1.7 μm thick
membrane modified electrodes after injection of 360 μL of 80 μM FcMeOH. The dashed
lines are the fitted curves. Using exponential least-squares regression, Equations 14 and
15 were calculated as best-fit functions for the 1.0 and 1.7 μm thick membrane modified
electrodes, respectively. The time constant (τ) value for the 1.7 μm thick membrane
modified electrode is 9.22 (Equation 15). Using Equation 13, τ=9.22, and a known film
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thickness of 1.7±0.2 μm a membrane diffusion coefficient of (1.6±0.3)x10-9 cm2/s was
calculated.
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Figure 3-7: Current-time transients following an injection of 360 μL volume of 80 μM
FcMeOH for the 1.0 and 1.7 μm membrane modified electrodes. Dashed-lines fitted to
the transients by exponential least-squares regression.

i (t ) 1.0 m  2.40  10 7  2.34  10 7 e

t
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i (t ) 1.7 m  1.38  10 7  1.29  10 7 e

t

9.22

(15)

R  0.991
2
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The time constant values derived in Equations 14 and 15, and the known
membrane thickness of 1.7 μm were used to calculate the thickness of the 1.0 μm thick
membrane. Because the diffusion coefficient for FcMeOH is the same for all membrane
thicknesses, Equation 13 can be rearranged to solve for an unknown film thickness.
Equation 16 shows the rearranged equation to solve for the unknown film thickness (δ).

1.7m 2
2
 DM 
2  9.22
2  3.028
3.3

(16)

Conclusion
These experiments showed that the AFAS can be used for automated voltammetric

analysis with membrane coated electrochemical cells, using ferrocenemethanol. The
sensitivity of the measurement is affected by the thickness of the membrane deposited on
the surface of the electrode. Thinner membranes have higher signal amplitudes and
better detection limits. By using thinner membranes, relatively small sample volumes
can be reproducibly measured in repeated experiments.
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4

MEASURMENT OF 2,6-DIISOPROPYLPHENOL USING THE AFAS IN
COMBINATION WITH THIN POLYMER FILM MODIFIED ELECTRODES
AND THE AFAS
The membrane covered, planar, microfabricated chip has been used to measure

propofol (2,6-diisopropylphenol). Propofol is highly lipophilic and has an octanol/water
coefficient of 6761:1.19 Since propofol is so lipophilic, it preferentially partitions into the
membrane from the aqueous solution. Figure 4-1 shows a schematic membrane coated
electrode at equilibrium. The concentration of propofol within the membrane (CM) is
expected to be much higher than in the aqueous sample solution (C0).

Film

Solution

CE
CM=κCS
Electrode

Cs

0

Stirred

C0

0

δ

x→

Figure 4-1: Schematic of the propofol concentration profiles in a membrane coated
electrode at equilibrium. Reproduced and modified from Marrese et al., Bard et al., and
Leddy et al.2, 50, 59
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The electrochemical oxidation of propofol is a complex process. Depending on the
experimental conditions, the products of the electrochemical oxidation may deposit onto
the working electrode surface, inducing serious electrode fouling. Electrode fouling is
common during the electrochemical oxidation of phenolic compounds.40, 68, 90 Electrode
fouling at solid electrodes may prevent their analytical use. The renewal of the electrode
surface by polishing or by electrochemical treatments may change the sensing surface
area.92 It was observed that electrode fouling, caused by propofol oxidation, could be
minimized by performing the cyclic voltammetry measurements in a limited potential
window47 or in an organic solvent.44
Similar to the experiments discussed in Chapter 3, a membrane modified gold
electrode was used for the measurement of propofol. Only limited information is
available on the direct electrochemical detection of propofol with a gold electrode.
Thiagarajan et al. and Langmier et al. have reported propofol measurements performed
with preanodized carbon and glassy carbon electrodes, respectively.47, 79 In this work,
microfabricated, planar gold macroelectrodes were modified with the PVC membrane.
These modified electrodes were used for propofol measurements. These experiments are
designed to: (i) determine the feasibility of automated voltammetric analysis of propofol
with the membrane coated electrodes; (ii) determine the precision and accuracy of
propofol measurement in the physiologically relevant concentration range; (iii) determine
the affect of electrochemically active compounds commonly present in human serum and
blood samples on propofol measurements; and (v) compare the performance of propofol
measurements with membrane coated sensor to that of ferrocenemethanol.
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4.1

Membrane Conditioning/Cleaning
The background currents with the membrane coated sensor were unexpectedly

large at potentials near the propofol oxidation potential. This large current was related to
impurities in the membrane. To reduce this current a conditioning/cleaning step was
necessary before the propofol measurements could be performed. The film modified
electrode was placed in a Buffer 2 solution, and the potential of the working electrode
was scanned between 1.2 and 1.8 V at a scan rate of 100 mV/s. The conditioning was
applied until the amplitude of the current decreased to a value of approximately 2x10-7 A
or remained constant across 10 consecutive scans. Figure 4-2b shows the conditioning
for a membrane coated gold macroelectrode in 1480 CVs. The current at 1.8 V decreased
from 2.4x10-6 A to approximately 4.8x10-7 A. For FcMeOH measurements with the
membrane coated electrode, conditioning was not required because FcMeOH has been
oxidized at much lower potentials where the impurities in the membrane did not
contribute to the background current. Figure 4-2a shows 10 CVs recorded between 0 and
0.5 V at a scan rate of 100 mV/s. In this potential window, the background current was
small, and there was no significant change in the signal across the 10 CVs.
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Figure 4-2: Membrane Cleaning using CV in Buffer 2 solution recorded with membrane
coated gold electrode. (a) CVs recorded between 0 to 0.5 V with a scan rate of 100
mV/s. (b) CVs recorded between 1.2 to 1.9V at a scan rate of 100 mV/s.

4.2

Results and Discussions
Before the flow analytical measurements of propofol with the AFAS, batch

experiments were performed. These experiments were performed to establish that: (i)
propofol measurements can be performed with a membrane covered electrode without
fouling of the sensing surface; and (ii) measurements can be performed within the
physiological concentration range of propofol.
For these measurements, the planar electrochemical cell was coated with a 1.0 μm
thick polymer film and exposed to an aqueous propofol solution. The large
macroelectrode located on the 2 μm MEA chip was used as the working electrode. A
platinum coil electrode was used as an external counter. A Ag/AgCl electrode was used
as an external reference. Buffer 2 was used as the background electrolyte. Figure 4-3
shows five CVs performed in 9.99 μM of propofol over a period of 20 minutes. A
potential window of 1.0 to 1.6 V and a scan rate of 100 mV/s was used. A beaker filled
with 10mL of Buffer 2 was spiked with 10 μL of 10-2 M propofol stock solution. In the
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1.9

initial CV, performed directly after the propofol addition (t=0 min), no faradic signal
related to propofol oxidation was detected. After five minutes another CV was
performed, and an oxidation peak for propofol was detected at a potential of 1.45 V vs.
Ag/AgCl. CVs were performed every five minutes in the same solution until the
propofol signal reached a steady-state. The CVs performed at 15 and 20 minutes have
the same peak current. It is assumed that the concentration of propofol in the membrane
is gradually increasing until it reaches a equilibrium with the aqueous solution. Based on
these measurements, the time needed to reach equilibrium is between 10 and 15 minutes.

t=0 min

t=5 min

t=10 min

t=15 min

t=20 min
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Figure 4-3: Cyclic voltammetry transients performed in 9.99 μM propofol + Buffer 2
solution performed over a period of 20 minutes. The potential of the working electrode
was scanned from 1 to 1.6 V at a scan rate of 100 mV/s. The working electrode is a gold
macroelectrode modified by a 1.0 μm thick membrane film. An external platinum coil
electrode was used as counter. An external Ag/AgCl electrode was used as reference.
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Monitoring of propofol during anesthesia requires a measurement frequency
which is less than 5 minutes per measurement. Consequently, measurements should be
performed before the sensor reaches steady state. If sequential measurements can be
performed using reproducible time intervals, measurements can be made without having
to wait for steady-state. FIA is ideally suited for these types of measurements.
CV measurements were performed in three minutes intervals in increasing
concentrations of propofol solution using 2 μm MEA microfabricated chip with a 1.0 μm
thick membrane coating. On the 2 μm MEA chip, the 0.0125 cm2 gold marcroelectrode
was used as the working electrode. The other 0.158 cm2 on-chip macroelectrode was
used as the reference and counter electrode.
A beaker of 10mL of Buffer 2 was spiked with 1 to 10 μL of aliquots of the
propofol stock solution. After each addition, the electrode was allowed to equilibrate in a
stirred solution for three minutes before a CV measurement was performed. The
potential of the working electrode was scanned from 1.0 to 1.9 V at a scan rate of 100
mV/s.
Figure 4-4a displays the CV transients performed in a concentration range of 1 to
90 μM propofol. As the concentration of propofol is increased, there is a corresponding
increase in the signal amplitude. In the measurements shown in Figure 4-4a, the peak
potential of the transients shift towards a more positive potential as the concentration of
propofol was increased. In measurements where an external reference electrode was used
in combination with a membrane coated working electrode, a stable peak potential was
maintained. To construct a calibration curve current values measured at 1.7 V were used.
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Figure 4-4b shows the calibration curve. A detection limit (DL=3xRMSD/Slope) of 6.2
μM was calculated.
This experiment demonstrates the feasibility of the quantitative measurement of
propofol with precision timing, e.g., measurements can be performed before steady-state
conditions are established. The AFAS is well suited to perform measurements where
precision timing is necessary.
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Figure 4-4: (a) Cyclic voltammetry transients performed in propofol concentrations from
1 to 90 μM propofol. The 2 μm MEA chip was modified by a 1.0 μm thick membrane
film. The small gold on-chip macroelectrode was used as the working electrode. The
large on-chip macroelectrode was used as the counter and reference electrode.
Concentration changes were made by standard additions 1 and 10 μL of 10-2 M propofol
stock solution into 10mL of Buffer 2 solution. After each standard addition, the system
was allowed to equilibrate for 3 minutes before a CV was performed. The potential of
the working electrode was scanned from 1 to 1.8 V at a scan rate of 100 mV/s. (b)
Calibration curve plotting the CV transient current at 1.7 V vs. the sample propofol
concentration.

.
4.2.1

Flow Injection Analysis with a Polymeric Membrane Coated Electrode
Although the therapeutic range of propofol is between 1 and 90 μM, the typical

blood concentrations are between 1 and 50 μM. The response of a 1.0 μm organic film
coated gold electrode was tested in this concentration range. On the 2 μm MEA chip, the
92
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0.0125 cm2 gold marcorelectrode was used as the working electrode. The other 0.158cm2
on-chip macroelectrode was used as the reference and counter electrode. The distance
between the injection site and the flow-through detector cell was 5.8 inches. The FIAAFAS in combination with the 6-PD valve was used to inject 540 μL propofol solutions
with concentrations ranging between 1.99 and 49.8 μM. The i-t transient is shown in
Figure 4-5. The first injection was performed 1200 seconds following the application of
the voltage. During these 1200 seconds the charging current decays to a background
current value.
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Figure 4-5: FIA i-t transient following the injections of 540 μL of 1.99, 9.99, 24.7, 39.8,
and 49.8 μM propofol solutions. The current was allowed to decay to a stable
background current for 1200 seconds before the first injection was made. Carrier
Solution: Buffer 2. Washing Time Between Injections: 3 minutes. Clamp-style flow
through cell. 6-PD Valve. Applied Potential: 1.8 V.
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The experiment shown in Figure 4-5 was repeated 5 times using the cycle control
for a total experiment time of 3 ½ hours. Figure 4-5 shows the DPHs across 5 cycles for
each concentration. Figure 4-6a shows the DPHs for 1.99 and 9.99 μM propofol
concentrations. Figure 4-6b shows the DPHs for 24.7 to 49.8 μM propofol
concentrations. The Grubbs‟ test was performed on the data to test for statistical outliers.
None of the DPH values could be considered as an outlier.
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Figure 4-6: Cycle-to-cyle DPHs from the FIA i-t transients are shown (a) 1.99 and 9.99
μM propofol concentrations, and (b) 24.7, 39.8, and 49.7 μM propofol concentrations
across 5 experimental cycles.

Table 4-1 displays the RSD values for the individual propofol concentrations
across the five cycles.

Table 4-1: RSD of the DPHs shown in Figure 4-6.
Concentration [μM]
1.99
9.99
24.7
39.8
49.8

RSD (n=5)
10.7%
4.5%
7.6%
10.9%
12.2%
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Figure 4-7a shows the calibration curve for Cycle 1. The DPHs taken from
Figure 4-6 are plotted versus the injected sample concentration. The slope values for all
5 cycles are plotted in Figure 4-7b. There is a 10.9% RSD (n=5) in the slope values. The
calculated detection limits (DL=3xRMSD/Slope) range between 7.5 (Cycle 5) and 13.3
μM (Cycle 2).
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Figure 4-7: (a) Calibration curve generated from DPHs of the FIA i-t transients in Cycle
1. (b) Cycle-to-cycle changes in the slopes of the calibration curves across the five
experimental cycles.

Attempts were made to generate calibration curves for smaller injected volumes
of propofol (i.e., 27 to 360 μL), similar to the FcMeOH volumes seen in Chapter 3.
However, these attempts were unsuccessful. The background current at 1.8 V is
approximately 50 times larger than the background current at 0.5 V, which was used
during the FIA experiments with FcMeOH in Chapter 3. To increase the sensitivity of
propofol measurements and to improve the DL, the propofol injected sample volume had
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to be increased. An injected volume of 540 μL was the minimum volume necessary to
perform an FIA experiment with propofol.
In Figure 4-8 the calibration curves for propofol (Figure 4-7a) and FcMeOH
(Figure 3-6) are compared. Although a direct comparison of the propofol data to the
FcMeOH data may not be justified, qualitative statements can be inferred. The larger
sensitivity of the propofol measurement is a result of its larger partition coefficient
compared to FcMeOH. The ratio of the two slopes does not reflect the partition
coefficients. This is due to the differences in the experimental conditions while recording
the two calibration curves. The FcMeOH DPH values represent the injected sample
concentrations without dispersion (i.e., steady-state values), while the propofol DPH
values represent sample concentrations which were not in steady state with the membrane
film. This lends support to the claim that propofol preferentially partitions into the
membrane, and provides a higher electrochemical signal compared to hydrophilic
compounds with same aqueous sample concentration.
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Figure 4-8: Comparison of the propofol calibration curve from Figure 4-7a and FcMeOH
calibration curve from Figure 3-8.

4.2.2

Flow Injection Analysis of Propofol in the Presence of Hydrophilic Interferences
Propofol measurements were performed in the presence of common hydrophilic

interfering compounds of 4-acetamido-phenol (i.e., acetaminophen, Tylenol) and Lascorbic acid. The oxidation potential for ascorbic acid (AA) was reported as 0.27 to
0.35 V vs. Ag/AgCl.95 The oxidation potential of acetaminophen (AC) was reported as
0.5 V vs. Ag/AgCl.41 The maximum blood concentration for adults who received a
1000mg dose of Adult Tylenol Liquid is approximately 126 μM.83 Serum concentrations
of AA have been reported as 54 to 64 μM.66
Interference concentrations of 7 times the propofol concentration were used to test
the interferences on the propofol signal. The interference concentrations were also
greater than the reported maximum serum concentrations. Analyte solutions of: (1) 158.4
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μM AA, (2) 142.9 μM AC, (3) 20 μM propofol, (4) 20 μM propofol + 158.4 μM AA and
(5) 20 μM propofol +142.9 μM AC were all formulated in Buffer 2. The 20 μM propofol
solution was chosen because it is a median concentration in the physiological
concentration range of propofol. To decrease the dispersion factor and to increase signal
amplitude, the length of tubing between the valve and the flow-through detector cell was
decreased to 2 inches. Unless otherwise stated, all other experimental conditions (i.e.,
valve, flow-through detector cell, etc.) were as described in 4.2.1.
Five sequential injections of the analyte solutions were made. Between sample
injections, a wash time of 10 minutes was used. The transient is shown in Figure 4.9.
The cycle control was used to automatically repeat the experiment 5 times, for a total
experiment time of 5 hours and 25 minutes.
It is apparent from Figure 4-9 that the presence of AA and AC causes some
interference in the propofol measurement. The response for propofol plus AC or AA is
greater than the response for propofol alone. Although the response for AA and AC
alone is not large compared when compared to the 20 μM propofol response, the presence
of AA or AC may be problematic when attempting to measure extremely low
concentrations of propofol.
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Figure 4-9: FIA i-t transient following the injection of 540 μL volumes of (1) 158.4 μM
AA, (2) 142.9 μM AC, (3) 20 μM propofol, (4) 20 μM propofol + 158.4 μM AA and (5)
20 μM propofol +142.9 μM AC solutions. The current was allowed to decay to a stable
background current for 600 seconds before the first injection was made. Carrier Solution:
Buffer 2. Wash Time: 10 minutes. Flow Rate: 540 μL/min. Applied Potential: 1.8 V.
Clamp-style flow through cell. 6-PD valve.

Figure 4-10 shows the changes in the background current and the peak currents
(i.e., absolute current value at Cmax) for the various propofol formulations (i.e., with and
without AA/AC) across all five experimental cycles. As shown in Figure 4-10a, the
background signal gradually increases over time. It is assumed that this increase is
related to the accumulation of propofol in the membrane, although a relatively long
washing time of 10 minutes was used. Because of propofol‟s highly lipophilic nature, it
may be impossible to completely remove all the propofol from the membrane by washing
with buffer alone. The data in Figure 4-10a suggests, that the membrane is slowly being
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saturated with propofol and a steady-state background value is being reached in the
membrane.
Figure 4-10b shows a gradual decrease in the peak currents across the five
experimental cycles. The gradual increase of propofol concentration in the membrane
may play some role in the gradual decrease in the current response. The decrease in the
peak heights indicates that the induced concentration change in the membrane over time
is decreasing.
Although there is a decrease in the measured peak heights over time, the RSDs
are not large. For the 20 μM propofol solution, the RSD of the peak currents is 2.6% in
the five experimental cycles. The peak currents for propofol + AC and propofol + AA
formulations had RSD values of 6.0% and 5.7%, respectively.
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Figure 4-10: Cycle-to-cycle changes in background current and peak height across five
experimental cycles. (a) Background current values from the FIA i-t transients for the
various propofol formulations across five experimental cycles. (b) Peak current values
from the FIA i-t transients for the various propofol formulations across five experimental
cycles.
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4.3

Conclusion
Although the feasibility of propofol measurements with the AFAS has been shown,

there is room for improvement. To produce a measurable signal, propofol FIA
measurements required significantly larger sample volumes compared to those used with
FcMeOH FIA measurements. Reduction of the necessary sample volume may be
possible by performing measurements in stopped flow mode, and allowing the membrane
to saturate for a period of time before a measurement is performed.
Overall, these measurements show that: (i) the AFAS can be used to perform
propofol measurements with a membrane modified electrode; (ii) propofol can be
measured with the membrane modified electrode without detrimental fouling; (iii)
changes in the measured electrochemical signal are directly proportional to changes in the
propofol sample concentration; and (iv) propofol preferentially partitions into the
membrane giving increased measurement sensitivity compared to hydrophilic
compounds.
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5

AFAS LIMITATIONS

5.1

Control Program/System
The control programs of the AFAS have been specifically designed to interface
with the instruments detailed in Section 1.2.1. Specific drivers were written to
control the Gilson peristaltic pump and the Hamilton MVP.

5.1.1

Electrochemical Characterization
Before the AFAS can be used for monitoring the concentration of a compound, the

electrochemical properties of the compound have to be investigated. The same
working and reference electrode used in these investigational measurements must also
be used with the AFAS.
1. In CV measurements the optimal potential for the CA experiments performed with
the AFAS must be determined.
2. In CV and/or CA experiments the magnitude of the measured current, in the
concentration range of interest, must be determined. The expected current value is
required for determining the appropriate gain setting on the BAS CV-27 potentiostat.
5.1.2

Flow System Characterization

Before the AFAS can be used for monitoring the appropriate following parameters
have to be determined in preliminary experiments:
1. How long it takes a sample plug of a given volume to travel from the point of
injection to the flow-through detector cell.
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2. .How long it takes a sample of a given volume to completely clear the flow-through
detector cell and for the measured signal to return to a background value. This will
determine the maximum sampling frequency.
3. The minimal sample volume necessary to achieve the required precision and accuracy
during monitoring.
4. The optimal flow rate.
5. The optimal distance between the injector and the detector, with or without a mixing
coil.
6. Whether the electrochemical measurements will be performed in flowing solutions or
under stopped flow.
Before the AFAS is used for monitoring, the user should ensure that the properties of
the solutions are in compliance with the specifications of the MVP valve.
5.2

Propofol Measurements with the AFAS
No measurements were made in serum, plasma, or whole blood. Consequently,

limitations related to measurements in theses samples are not known at this time. The
usage life and shelf life of the propofol sensor are unknown at this time. No
measurements were made with propofol injectable emulsion solution. It is unknown how
the highly lipophilic compounds present in the injectable emulsion solution will affect the
hydrophobic membrane.
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6

CONCLUSIONS AND FUTURE WORK
The goal of this work was to: (1) develop and automated flow analytical system; (2)

demonstrate its performance characteristics in a variety of sampling and fluidic schemes;
(3) show its performance characteristics in combination with a film modified
electrochemical sensor; and (4) show the feasibility of propofol monitoring with the
AFAS.
The completed experiments emphasize the capability of the AFAS as an
automated flow analytical system. The AFAS is able to accurately meter analyte
volumes down to 5 μL, and perform electrochemical measurements in both flowing and
stopped flow solutions. Precision timing allows experiments to be repeated the same way
every time. The AFAS can be used in continuous monitoring situations, and has been
used to perform periodic measurements every 5 minutes for 6 ¾ hours. Accurate
measurements can be made both in stopped-flow and flowing solutions. Flow injection
analysis can be performed, and the AFAS has the ability to isolate and perform
electrochemical measurements on specific regions of an injected sample plug.
The feasibly of long term voltammetric measurements with membrane coated
electrodes were also shown. Measurements made with ferrocenemethanol had an average
RSD of 1.7% for the 1.0 μm thick membrane modified electrode. Detection limits of 5±2
μM were calculated for the 1.0 μm thick membrane modified electrode
Long-term voltammetric measurements made with propofol also showed promise.
Measurements were made using propofol concentrations within the physiological range.
Experiments showed that hydrophilic interferences hardly influence the signal of the
membrane coated propofol sensor.
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Future propofol experiments will focus on using a glassy carbon electrode
because of its larger sensitivity, compared to the gold electrode, to phenolic compounds.
Also, experimental protocols will be developed to perform measurements in stopped-flow
mode to reduce the necessary sample volume. Future experiments will also compare the
performance characteristics of the propofol sensor in the presence and absence of
different levels of albumin in the sample solutions. Lastly, the electrochemical activity
and possible interferences of the propofol injectable emulsion solution will be examined.
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7

APPENDIX A: AFAS MANUAL
The automated flow analytical systems (AFAS) is composed of a flow-through

electrochemical cell, a computer controlled actuator (Modular Valve
Positioner (367898), Hamilton Company, Reno, NV), multi-position valve (6-port
Distribution Valve/6-port Loop Valve (36781/ 38760), Hamilton Company, Reno, NV),
peristaltic pump (Miniplus3 Peristaltic Pump (F1155006), Gilson Incorporated,
Middleton, WI), and potentiostat (CV-27 Cyclic Voltammagraph (MF9030), in
combination with a PA-1 Pre- Amplifier (MF2200), Bioanalytical Systems Incorporated,
West Lafayette, IN). The AFAS has a user-friendly graphical interface, which allows for
easy configuration of the system. The user interface was designed using LabVIEW
(National Instruments Corporation, Austin, TX).
7.1

AFAS Components Overview
Figure 7-1 shows a schematic view of the instrument communication/control and

the fluid pathways. The computer contains the control program that communicates with
each instrument in the system. Each of the instruments are connected to the computer
through various interfaces. The potentiostat is connected to the computer via the NI-6221
DAQ card and USB port. The Modular Valve Positioner (MVP) is connected directly to
the computer via the COM1 serial port. The peristaltic pump is connected to the
computer via the 506C interface and the COM2 serial port. Analytes/reagents are
selected by the MVP. The peristaltic pump is used to flow the selected analyte/reagent.
The selected analyte/reagent passes through the flow-through electrochemical cell which
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houses the electrode/sensor and is deposited in a waste container. Brief descriptions of
each instrument are detailed below. For a full description of the instrument operation

NI-6221

COM2

USB

refer to the individual instruction manuals.

Computer

Gilson 506C
Interface

COM1

BAS CV27
BAS PA1
Potentiostat

GSIOC Cable

Flow-Through
Electrochemical
cell

Gilson Minipulse3
Peristaltic Pump

Communication Lines

Waste

Fluid Lines

Hamilton MVP
Sampling Valve
Samples
Figure 7-1: AFAS communication and fluid flow

7.2

Bioanalytical Systems (BAS) Potentiostat and Amplifier
The control program interfaces with the BAS model CV-27/PA-1 potentiostat via

the NI-USB-6221 Multifunction DAQ. Figures 7-2 and 7-3 display the front and rear
panel of the CV-27. To perform electrochemical measurements the waveform of the
desired electrochemical technique is sent from the control program to the DAQ interface
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card, which applies the equivalent voltage waveform to the Voltage Input Terminal (VIT)
located on the rear panel of the BAS potentiostat. The BAS potentiostat then applies the
input voltage to the working electrode and the current response received by DAQ is saved
by computer. The Cell Mode, located on the front panel, should be set to CELL during
an experiment and be turned to STBY (i.e., standby) after the experiment. When set to
CELL the electrode/sensor is connected to the CV-27 electronics. When set to STBY the
electrode/sensor is not connected.

Figure 7-2: Front panel of the CV-27.4

Figure 7-3: Rear panel of the CV-27.4
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The Initial E knob (V), located on the front panel, is a dual function knob that
controls initial potential that is applied when the cell is connected and a voltage
waveform is not being applied to the VIT. The control program should be used to set this
potential. The knob should only be used to make small adjustments so that the actual
potential applied matches the accumulation potential set by the AFAS.

The Gain knob (mA/V) is located on the front panel. The gain serves a dual
function as a current to voltage conversion and an amplification factor. The gain should
be set according to expected current range from the electrode/sensor.

The rear panel of the BAS potentiostat is used primarily to connect to external
devices for input, recording, and power. The rear controls of note are described below.
The Cell port allows the connection between the electrochemical cell and the electronics.
The red, white and black wires of the cell connector cable should be connected to the
auxiliary/counter, reference, and working electrodes; respectively. I Out (V) outputs the
voltage based on the current-to-voltage converter/gain control on the front panel. The
voltage is directly proportionally to the current being generated by the electrochemical
reaction. The conversion factor is the gain setting on the front panel. The App. E output
is the potential applied to the working electrode of the electrochemical cell.

7.3

BAS PA-1 Amplifier
If using a microelectrode it is recommended that the BAS PA-1 Amplifier be used.

The front and rear panels of the PA-1 are displayed in Figures 7-4 and 7-5.
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Figure 7-4: Front panel of the PA-1 Amplifier. Taken from Reference 5

Figure 7-5: Rear panel of the BAS PA-1 Amplifier. Taken from Reference 5

The Cell Mode is a toggle switch located on the front panel. To connect the PA-1
electronics to the electrochemical cell, the control switch should be set to ON. Otherwise
it should be set to OFF.
The Gain knob is used to set the amplification and the current-to-voltage
conversion factor. The Multiplier knob sets a number in which the gain is multiplied by.
When the PA-1 is used in combination with the CV-27 the total gain (A/V) is calculated
by Equation 17.

GainTotal 

Gain PA 1 (amperes / volt)  Multiplier  GainCV  27 (amperes / volt)
100  10 6
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(17)

The PA-1 is connected to the electrochemical cell through a control box located
on the faraday cage.

Figure 7-6: Rear panel of BAS PA-1 with connection to faraday cage.5

The Low Current Input port, located on the rear of the PA-1port is connected to
the faraday cage through a connector cable (Figure 7-6). When using the PA-1 in
combination with the CV-27 the Cell port, located in the rear of the CV-27, should be
connected to the Cell port located on the faraday cage. On the inside of the faraday cage
are cables to connect to the electrochemical cell. The color codes are the same as
described above for the CV-27 cable.
7.4

NI-6211 Data Acquisition (DAQ) Instrument
The NI-6211 DAQ hardware digitizes signals, performs digital to analog

conversions to generate analog output signals, and measures analog input signals 63. The
NI-6211 is connected to the computer via an USB port. This connection allows the
control program to interface with the BAS model CV-27/PA-1 potentiostat via the NIUSB-6221. To perform electrochemical measurements, the waveform of the desired
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electrochemical technique is sent from the control program to the DAQ interface card
which applies the equivalent voltage waveform to the voltage input terminal (i.e., the Ext.
In. jack) at the rear of the BAS potentiostat. The BAS potentiostat then applies the input
voltage to the working electrode. The NI-6211 receives input from the I Out and App. E
output jacks. The I Out jack sends the response current to the applied potential to the
control program via the NI-6211. The App. E sends the actual applied potential to the NI6211. This potential along with the I Out current is used by the control program to
construct the cyclic voltammetry response curve. The chronoamperometric response
curve is constructed using current from the I Out jack and the time from the applied
chronoamperometric waveform.
7.5

Hamilton Modular Valve Positioner
The Hamilton Modular Valve Positioner (MVP) automatically changes the position

of the installed valve according to an electronic command sent through the COM1
port. The MVP has a rotation speed of 20 RPM. It is able to perform a complete
revolution in three seconds, in either the clockwise or counterclockwise direction. The
control program has the ability to determine the shortest path to the required valve
position. This functionality allows for any valve position to be accessed within 1.5
seconds.
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Figure 7-7: Front and rear panels of the MVP.33

The front and rear panels of the Hamilton MVP are shown in Figure 7-7. The
valves should be locked into the valve connector port located on the front panel. The
valve indexing pin should be lowered. The MVP Input port should be connected to the
COM1 port of the computer.
7.5.1

Valves
At this time our lab has two Hamilton MVP valves in stock. A schematic of the

valves depicting their fluidic profiles are shown in Figure 7-8.
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LOAD

INJECT

b.

Figure 7-8: Valve schematics.32

Each MVP valve has an internal cylinder that can be rotated in the clockwise or
counterclockwise direction. The rotation of the cylinder in the 6-Port Distribution (6-PD)
valve allows for the selection of analyte/reagent solutions from 6 inlet ports.(Figure 7-8a)
The 6-PD valve has a dead volume of 27.2 μL.

The 6-Port Loop (6-PL) valve is rotated to change the orientation to two flow
configurations, Load and Inject. In the Load position the attached sample loop is
bypassed. In Inject position the sampled loop is connected, and the sample washed to the
detector. The 6-PV valve has a dead volume of 7.5 μL.

Presently, the Hamilton MVP is electronically calibrated to use a 6 port valve. For
information on how to change the MVPs configuration please refer to the Hamilton MVP
User Manual.
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7.6

Gilson Peristaltic Pump and 506C Interface

The Gilson peristaltic pump is used to pump the solution selected by the Hamilton
MVP into the flow-through cell. It is controlled via the Gilson 506C System Interface.
The control program is used to set the flow rate of solution, and start/stop the pump.

The 506C Interface is connected to the computer via the COM2 serial port and the
RS232 located at the rear of the 506C Interface. A RS485 level cable is then connected
from the GSIOC port, at the rear of the 506C Interface, to the GSIOC port located at the
rear of the Miniplus3.

7.7

Flow Analytical and Flow Injection Analysis Programs
There are two control programs for the AFAS. The graphical interfaces of the

programs are similar in design and functionality, each having many of the same dropmenus, pop-up windows, controls and indicators.
7.7.1

Graphical Interface Description
The graphical interface for each control program is displayed in Figures 7-9 and

7-10. The interface is made of up of controls (parameters that require user input) and
indicators (parameters that display information about the experiment). The graphical
interface of the FA program is divided into five sections, and the FIA program is divided
into seven sections.
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Figure 7-9: Graphical interface of the FA program, with numbered sections 1 to 5.
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Figure 7-10: Graphical interface of the FIA program, with numbered sections 1 to 7.
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7.7.1.1 Section 1 - Experimental Procedure
Experimental Protocol Control – The experimental protocol control is a key
component in the control program. This control allows the user to input an experimental
protocol using one line/row for each step in the experimental procedure. Each step in the
experimental procedure is composed of a cluster of five elements (1) Valve Position (2)
RPM, (3) Pump Time, (4) Wait Time and (5) Measure Control. These elements are
explained in detail below.
a) Valve Position – This control allows the user to select a specific valve position for
a specific protocol step. This control is a menu selection type control. The user
should click on the downward arrow by the valve control box to select the valve
position from a menu.
b) RPM – The RPM (rotations per minute) control allows the user to select the
rotation speed of the peristaltic pump for a specific protocol step. This control is
a numerical control. The user should enter a decimal numerical value.
c) Pump Time – The pump time control specifies how long the pump will be active
for a specific protocol step. This control is a numerical control. The user should
enter an integer numerical value.
d) Wait Time – The wait time control specifies a wait time for a specific protocol
step. If measure control is active then the pump will be deactivated during the
wait time and a measurement will be done in stopped-flow mode (no solution
flowing). If a wait time is not specified and the measure control is active the
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measurement will be done in hydrodynamic mode (solution flowing). This
control is a numerical control. The user should enter an integer numerical value.
e) Measure – The measure control specifies if a measurement will be taken during a
specific step of the experimental protocol. This is a Boolean control. It is either
ON or OFF. A green, oval LED is used for this control. When the LED is brightgreen measurement if ON at that step. When the LED is opaque-green
measurement is OFF for that step.
Section 1 is the same in both the FA and FIA programs, except the FIA program does not
contain a Measure control.
7.7.1.2 Section 2 - Drop-Down Menus and Pop-Up Windows
Section 2 contains the drop-menus. The menus were designed to increase the
functionality of the control programs and to optimize use of the available display space.
The Experimental Procedure menu (Figure 7-11) contains options that affect the
Experimental Procedure. The options are as follows:
1. New (Short-cut Key: Ctrl+N): Loads a new/empty experimental procedure
2. Open (Short-cut Key: Ctrl+O): Loads a previously saved experimental procedure
3. Start (Short-cut Key: Ctrl+S) : Starts the experimental procedure
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Figure 7-11: Experimental Procedure program menu

The Valve menu (Figure 7-12) allows the user to select the valve that is currently
in use in the system. The menu options are as follows:
1. 6 Position (Ctrl+P) – Allows the user to select the six position distribution valve.
2. 6 Loop (Ctrl+L) - Allows the user to select the six position loop valve.
Selection of either valve option opens a pop-up window and allows the user to specify the
solutions attached to each position. Figure 7-13 displays the pop-up configuration
windows for each of the valves. The user can also use the default position names by
checking the Use Label Names check box.

Figure 7-12: Valve program menu
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a.
b.
Figure 7-13: Pop-up windows for valve configuration for (a) the 6-PD valve and (b) the
6-PL valve.

The Electrochemical Parameters menu (Figure 7-14) allows the user to select
from two electroanalytical techniques. This menu option is not available in the FIA
program. Selection of either menu option opens a pop-up window which allows the user
to enter the technique parameters. The waveform approximation of the parameters is
displayed on the front panel. Figure 7-15 displays the pop-up configuration window for
each of the electrochemical techniques and the Waveform Display. The Waveform
Display is a graphical representation of the technique parameters. The pop-up menu
options are as follows:
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1. Cyclic Voltammetry (Crtl+Y) - A triangular potential waveform is written to the DAQ
card. The applied waveform is configured by entering the waveform parameters in the
Cyclic Voltammetry Parameters pop-up window (Figure 7-15a).
a. Accumulation Potential (volts) – The accumulation potential is the potential set
before the cyclic voltammetry waveform is applied. The accumulation potential
allows the electrode to equilibrate before the CV triangular function is applied.
b. Accumulation Time (seconds) – The amount of time in which to apply the
accumulation potential.
c. Initial Potential (volts) – After the accumulation time the potential is set to this
initial potential. This is initial potential for the cyclic voltammetry waveform.
d. Potential Limit 1 (volts) – Potential limit 1 is the first voltage in which the
waveform will be scanned to.
e. Potential Limit 2 (volts) – Potential limit 2 is the second voltage in which the
waveform will be scanned to.
f. Scan Rate (volts/second) – The scan rate specifies the number of volts to apply
per second. The scan rate determines the total time to apply the cyclic
voltammetry waveform.
g. Number of Scans – The number of scans determines how many scans there will be
in the applied CV waveform.
2. Chronoamperometry (Ctrl+H) - A pulse potential waveform is written to the DAQ
card. The applied waveform is configured by entering the waveform parameters in the
Chronoamperometry Parameters pop-up window (Figure 7-15b).
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a. Accumulation Potential (volts) – The accumulation potential is the potential
set before the chronoamperometric waveform is applied.
b. Accumulation Time (second) – The amount of time in which to apply the
accumulation potential.
c. Potential 1 (volts) – After the accumulation time the potential is set to this
initial potential. This is initial potential for the chronoamperometric
waveform.
d. Potential 2 (volts) – After Potential 1, this is the voltage in which the
chronoamperometric waveform is stepped to.
e. Time 1 (second) – Time 1 is the length of time in which Potential 1 is applied.
f. Time 2 (seconds) – Time 2 is the length of time in which Potential 2 is
applied.
g. Number of Steps – The number of steps in the chronoamperometric waveform.

Figure 7-14: Electrochemical Parameters program menu

The chronoamperometric technique parameters are located in Section 4 of the FIA
program. In this section the user is able to select from two options, Experiment and Tube
Filling. If the Experiment option is selected the user is able to enter the parameters for
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the chronoamperometric pulse. The Time 1 and Time 2 parameters are automatically
adjusted to apply a pulse for the length of the experimental procedure. If the Tube Filling
option is selected the chronoamperometric technique parameters are grayed out and
disabled, and no chronoamperometric pulse is applied during the experimental procedure.

Figure 7-15: Pop-up configuration window for (left) cyclic voltammetry and (right)
chronoamperometry and the Waveform Display.

7.7.1.3 Section 3 - File Saving, Applied Waveform, Cycles
The following controls are located in section three of FA program. Unless otherwise
noted, these controls are also located in Section 3 of the FIA program.
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1. Cycles – The cycle control determines how many times the experimental protocol
will be run. This control allows the AFAS is to automatically perform repeated
experiments.
2. Path to Write – This is the folder path in which the protocol and any data will be
saved. This path must be manually created before the experiment is started.
3. File Name – This is the file name under which the experimental protocol and any
experimental data will be saved. The data will be saved as a TXT and TDMS file
type, and the experimental procedure will be saved as a DAT file type.
4. Gain (A/V) – This is the amplification and voltage to current conversion factor set
on the CV-27 and PA-1 instruments. (Note: This feature is located in Section 5 of
the FIA program)
5. Replicate – This control copies the experimental procedure steps already loaded.
A new experimental procedure, with the original experimental procedure
replicated the inputted number are times, is automatically loaded. (Note this
feature is only available in the FIA program)
6. Description – This control is a text box where the user can type in a short
description of the experiment. The description is included in the TDMS data file.
7. Applied Waveform - The applied waveform is a graphical representation of the
electrochemical technique parameters.
8. User – This control is a text box where the user enters his/her name. This
information is included in the TDMS data file.
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7.7.1.4 Section 4 and 6– Experimental Indicators
The following indicators are located in Section 4 of the FA program. These
indicators are located in Section 6 of the FIA program.
1. Present Cycle – This indicator displays in which cycle the protocol is currently
running.
2. Present Step - This indicator displays the step in the experimental procedure that
is currently running.
3. Pump Time Left (HH:MM:SS) – This indicator displays the amount of pump time
left in the current protocol step.
4. Wait Time Left (HH:MM:SS) – This indicator displays the amount of wait time
left in the current protocol step.
5. Total Time (seconds) – The indicator displays the time it takes to run the
measurement.
6. Accumulation Time (seconds) – This indicator displays the current progress of the
accumulation time for the measurement for the current protocol step.
7. Elapsed Time (seconds) – This indicator displays the amount of time that has
elapsed since the beginning of the measurement.
8. Number of Data – This indicator displays the number of data points that will be
taken during measurement.
9. Total Time P/W (seconds) – This feature is only available in the FIA program.
This indicator displays the amount of time need to complete all steps in the
experimental procedure.
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10. Indexed File Name – This indicator displays the File name with a numerical
indicator of the Experimental Procedure step (in the case of FA program) and
cycle number appended to it.
7.7.1.5 Section 5 and 7 - Measured Signal and Sample Rate
Section 5 of the FA program and Section 7 of the FIA display the Measured
Signal. The Measured Signal is a graphical representation of the electrode/sensor
response to the applied waveform. Section 5 of the FIA program displays the Gain (A/V)
and Sample Rate control. The Sample Rate control indicates time interval in seconds
between collected samples.
7.7.2

How the Programs Work
The selected program is activated by pressing LabVIEW‟s Run button. This

button is a white arrow located in the toolbar below the File menu toolbar. It is
highlighted with a red box in Figure 7-16. Once the program is activated, LabVIEW‟s
File menu toolbar will be replaced by the program specific toolbar (i.e., Experimental
Procedure, Valve, and Electrochemical Parameters). The user must enter all pertinent
information into the program (Experimental Procedure, File path, File name, Gain, etc.).
The experimental procedure is started by selecting Experimental Procedure→ Start
from the program toolbar. The program interprets each step in the experimental
procedure as programmed and sequential activation of each of the system instruments.
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Figure 7-16: Experimental procedure for the (left) FA and (right) FIA programs

Figure 7-16 displays a three-step experimental procedure entered in the FA
program (Left) and the FIA program (Right). In the FA program the user controls when a
measurement will take place. In the case of the FA program, the experiment proceeds as
follows:
1. Load the 1st step in the experimental procedure
a. Send electronic command to the MVP and rotate the valve to Position 1.
b. Send electronic commands to the peristaltic pump to (1) set pump tumbler
rotation speed to 5 RPM and (2) activate rotation.
c. The system then counts down the pump time from 30 seconds to zero
d. Wait time is 0, do nothing.
e. Measure is not active, do nothing.
2. Load the 2nd step in the experimental procedure.
a. Send electronic command to the MVP and rotate the valve to Position 2.
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b. Send electronic commands to the peristaltic pump to (1) set pump tumbler
rotation speed to 5 RPM, and (2) activate rotation.
c. The system then counts down the Pump Time from 60 seconds to zero
d. Send an electronic command to stop pump. The system counts down the
wait time from 3 to zero.
e. The Measure Boolean is active. The system applies the selected
electrochemical technique and reads the response from the
electrode/sensor.
3. Load the 3rd step in the experimental procedure.
a. Send electronic command to the MVP and rotate the valve to Position 1.
b. Send electronic commands to the peristaltic pump to (1) set pump tumbler
rotation speed to 1 RPM, and (2) activate rotation.
c. The system then counts down the Pump Time from 200 seconds to zero
d. Send an electronic command to stop pump. The system counts down the
wait time from 3 to zero.
e. The Measure Boolean is active. The system applies the selected
electrochemical technique and reads the response from the
electrode/sensor.
Essentially the same experimental procedure is loaded in the FIA program (Figure
7-16 Right), except there is no step-by-step measurement control. The measurement is
performed over the entirety of the experimental procedure. There is also a difference in
how the data is outputted. With the FA program, two data files will be generated,
because two measurement steps were performed. With the FIA program, one data file
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will be generated because one measurement was performed over the entirety of the
experimental procedure.
7.7.3

Outputted Data Files
Three data file types (DAT, TXT, and TDMS) are automatically saved at the end

of the experiment. The DAT file contains the experimental procedure. The TXT file
contains the electrochemical response data is ASCII format. This file can be opened in a
numerical spreadsheet program (e.g., Excel, Origin, etc.) for analysis. The TDMS file
can be opened in DIAdem, a data management and processing software from National
Instruments. The TDMS contain the electrochemical response data and the searchable
parameter listed below. The parameters may be searched independently or in
combination.


User



Scan Rate,



Experiment Date/Time



Number of Scans



File Name



Number of Steps



Accumulation Potential and Time



Electrode/Sensor Identification,



Initial Potential



Electrochemical Technique



Potential 1



Potential 1 Time



Potential 2



Potential 2 Time

In the TDMS file the parameters are grouped under the specific channels: Sensor
Information, Experiment Information, Electrochemical Results, and Electrochemical
Parameters. Figure 7-17 shows an expanded view of an experimental data file loaded in
DIAdem's data portal.
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Figure 7-17: Diadem program with TDMS data file loaded

Visual Basic scripts, used for automated data analysis, are written in DIAdem.
The scripts perform the following data manipulation: FFT, Low Pass Filter, Steady State
Value, Peak Value, Area Under Curve (Charge).
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8

APPENDIX B: STATISTICAL DATA

Table 8-1: DPH (Amperes) values for 6-PD and 6-PL valves. *Statistical outlier by
Grubbs‟ test. (Data discussed in Section 2.5.1.1)
6-PD
2.1E-06*
1.7E-06
1.7E-06
1.6E-06
1.6E-06
1.7E-06
1.6E-06
1.5E-06
1.5E-06
1.5E-06
1.7E-06
1.6E-06
1.6E-06
1.5E-06
1.5E-06
1.6E-06
1.6E-06
1.6E-06
1.5E-06
1.5E-06

6-PL
1.8E-06
1.7E-06
1.6E-06
1.6E-06
1.7E-06
1.7E-06
1.5E-06
1.5E-06
9.9E-07
1.6E-06
1.8E-06
1.5E-06
1.5E-06
1.6E-06
1.6E-06
1.8E-06
1.6E-06
1.5E-06
1.6E-06
1.6E-06
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t-Test: Two-Sample Assuming Equal Variances

Mean
Variance
Observations
Pooled Variance
Hypothesized Mean Difference
df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail

6-PD
6-PL
1.58E-06 1.59E-06
4.6E-15 2.86E-14
19
20
1.69E-14
0
37
-0.28533
0.388492
1.687094
0.776984
2.02619

Figure 8-1: t-Test of data in Table 8-1. Statistical outliers excluded. (Data discussed in
Section 2.5.1.1)

Table 8-2: Detection Limit (moles/L) calculated from 10 cycles of experiment at t=0.5,
1, 2, 5, 19, 20, and 58 s. Detection Limits calculated using 3x‟s RMSD divided by slopes
of calibration curves. (Data discussed in Section 2.5.3)
0.5s
(moles/L)
6.8E-06
4.4E-06
2.9E-06
7.8E-06
8.1E-06
4.7E-06
3.0E-06
7.4E-06
7.4E-06
3.0E-06

1.0s
(moles/L)
6.0E-06
4.1E-06
5.3E-06
5.3E-06
8.2E-06
4.1E-06
4.2E-06
8.1E-06
7.3E-06
4.2E-06

2.0s
(moles/L)
8.1E-06
5.9E-06
5.5E-06
4.7E-06
8.0E-06
6.1E-06
4.0E-06
6.1E-06
5.6E-06
6.5E-06

5.0s
(moles/L)
7.8E-06
6.7E-06
7.9E-06
5.5E-06
8.0E-06
5.6E-06
3.4E-06
7.3E-06
5.4E-06
5.1E-06
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10.0s
(moles/L)
9.2E-06
6.0E-06
5.2E-06
3.8E-06
6.9E-06
4.0E-06
4.2E-06
5.7E-06
7.8E-06
6.0E-06

20.0s
(moles/L)
1.0E-05
5.7E-06
8.3E-06
3.5E-06
5.7E-06
6.3E-06
4.3E-06
5.3E-06
7.1E-06
4.9E-06

58.0s
(moles/L)
8.1E-06
5.0E-06
5.7E-06
3.1E-06
5.6E-06
5.3E-06
2.5E-06
5.6E-06
6.4E-06
4.8E-06

Anova: Single Factor
SUMMARY
Groups
.5 Seconds
1 Second
2 Seconds
5 Seconds
10 Seconds
20 Seconds
58 Seconds

Count
10
10
10
10
10
10
10

ANOVA
Source of Variation
SS
Between Groups 7.97E-12
Within Groups
1.84E-10
Total

1.92E-10

Sum
5.53E-05
5.69E-05
6.05E-05
6.25E-05
5.88E-05
6.11E-05
5.21E-05

df

Average
5.53E-06
5.69E-06
6.05E-06
6.25E-06
5.88E-06
6.11E-06
5.21E-06

MS
6 1.33E-12
63 2.92E-12

Variance
4.6E-12
2.75E-12
1.62E-12
2.24E-12
2.98E-12
3.77E-12
2.45E-12

F
P-value
F crit
0.45549 0.83842 2.246409
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Figure 8-2: ANOVA of data in Table 8-2. (Data discussed in Section 2.5.3)

Table 8-3: Slope values (Amperes Liter/mole) calculated from linear least-squares
regression of calibration curves across 10 experimental cycles. *Statistical outliers
verified by Grubbs‟ Test. (Data discussed in Section 2.5.4)

Slope 1
Slope 2
Slope 3
Slope 4
Slope 5
Slope 6
Slope 7
Slope 8
Slope 9
Slope 10

Day 1
(A/M)
4.6E-04
4.6E-04
4.5E-04
4.5E-04
4.7E-04
4.5E-04
4.5E-04
4.5E-04
4.7E-04
4.9E-04*

Day 4
(A/M)
5.2E-04*
5.0E-04
4.9E-04
4.9E-04
5.0E-04
4.9E-04
4.9E-04
4.9E-04
4.8E-04
5.0E-04
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Day 7
(A/M)
5.0E-04
5.0E-04
4.8E-04
5.0E-04
4.9E-04
4.5E-04*
4.8E-04
4.9E-04
4.9E-04
5.0E-04

Anova: Single Factor
SUMMARY
Groups
Day 1
Day 4
Day 7

Count

Sum
Average
9 0.00410995 0.000457
9 0.004434154 0.000493
9 0.004418437 0.000491

ANOVA
Source of Variation
Between Groups
Within Groups

SS
7.42665E-09
1.55453E-09

Total

8.98118E-09

df

MS
2 3.71E-09
24 6.48E-11

Variance
6.19E-11
5.58E-11
7.66E-11

F
P-value
F crit
57.3291 7.23E-10 3.402832
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Figure 8-3: ANOVA of data in Table 8-3. Statistical outliers removed. (Data discussed
in Section 2.5.4)

t-Test: Two-Sample Assuming Equal Variances

Mean
Variance
Observations
Pooled Variance
Hypothesized Mean Difference
df
t Stat
P(T<=t) one-tail
t Critical one-tail
P(T<=t) two-tail
t Critical two-tail

Day 4
Day 7
0.000493 0.000491
5.58E-11 7.66E-11
9
9
6.62E-11
0
16
0.455316
0.3275
1.745884
0.655
2.119905

Figure 8-4: t-test of Day 4 and Day 7 data in Table 8-3. Statistical outliers removed.
(Data discussed in Section 2.5.4)
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Table 8-4: SD values (Amperes) of five DPH measurements (n=5) for each injected
volume and concentration for the unmodified electrode. The 64 μL injected volume was
removed because of missing data. (Data discussed in Section 3.2.1)
27 μL
45 μL
90 μL
180 μL
360 μL

5 μM
7.1E-10
8.2E-11
8.8E-11
1.7E-10
5.4E-11

20 μM
6.2E-10
6.8E-10
4.4E-10
5.4E-11
3.8E-10

40 μM
2.4E-09
1.8E-09
8.3E-10
5.8E-10
1.5E-10

Anova: Two-Factor Without Replication
SUMMARY
Count
Sum
27μL
5
5.2E-09
45μL
5
3.7E-09
90μL
5
4.8E-09
180μL
5
2.8E-09
360μL
5
1.3E-09
5μM
5
1.1E-09
20μM
5
2.2E-09
40μM
5
5.7E-09
60μM
5
3.9E-09
80μM
5
4.9E-09
ANOVA
Source of Variation
SS
df
Rows
2.0E-18
4
Columns
2.9E-18
4
Error
6.1E-18
16
Total

1.1E-17

60 μM
1.3E-09
8.2E-10
1.1E-09
5.2E-10
1.4E-10

Average
1.0E-09
7.4E-10
9.6E-10
5.5E-10
2.6E-10
2.2E-10
4.3E-10
1.1E-09
7.8E-10
9.7E-10
MS
5.0E-19
7.2E-19
3.8E-19

80 μM
1.5E-10
3.5E-10
2.4E-09
1.4E-09
5.7E-10

Variance
7.5E-19
4.2E-19
7.5E-19
2.9E-19
4.5E-20
7.6E-20
6.1E-20
8.4E-19
2.2E-19
8.4E-19
F
1.30
1.89

P-value
0.311
0.1622

F crit
3.0069
3.0069

24

Figure 8-5: Two-Factor ANOVA of SD values in Table 8-4 for each injected volume and
concentration for unmodified electrode. (Data discussed in Section 3.2.1)
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Table 8-5: SD values (Amperes) of five DPH measurements (n=5) for each injected
volume and concentration for the 1.0 μm thick membrane modified electrode. (Data
discussed in Section 3.2.1)
27 μL
45 μL
64 μL
90 μL
180 μL
360 μL

5 μM
4.7E-10
6.5E-10
1.7E-10
1.1E-10
8.7E-11
4.6E-10

20 μM
4.8E-10
1.8E-10
1.5E-10
5.4E-10
2.6E-11
2.0E-10

40 μM
1.3E-09
1.0E-09
1.1E-09
3.5E-11
2.8E-10
8.0E-10

Anova: Two-Factor Without Replication
SUMMARY
Count
Sum
27μL
5
5.5E-09
45μL
5
2.1E-09
64μL
5
3.2E-09
90μL
5
2.9E-09
180μL
5
1.6E-09
360μL
5
3.8E-09
5μM
6
1.9E-09
20μM
6
1.6E-09
40μM
6
4.5E-09
60μM
6
5.5E-09
80μM
6
5.6E-09
ANOVA
Source of Variation
SS
df
Rows
1.9E-18
5
Columns
2.5E-18
4
Error
8.1E-18
20
Total

1.3E-17

60 μM
2.9E-09
1.9E-10
7.7E-10
1.3E-09
2.5E-10
1.1E-10

Average
1.1E-09
4.2E-10
6.3E-10
5.8E-10
3.3E-10
7.6E-10
3.2E-10
2.6E-10
7.5E-10
9.2E-10
9.3E-10
MS
3.9E-19
6.2E-19
4.1E-19

80 μM
4.4E-10
2.5E-11
1.0E-09
8.7E-10
9.9E-10
2.2E-09

Variance
1.1E-18
1.8E-19
2.0E-19
2.9E-19
1.5E-19
7.5E-19
5.4E-20
4.0E-20
2.4E-19
1.1E-18
5.6E-19
F
0.96
1.53

P-value
0.4675
0.2304

F crit
2.7109
2.8661

29

Figure 8-6: Two-Factor ANOVA of SD values in Table 8-5 for each injected volume and
concentration for the 1.0 μm thick membrane modified electrode. (Data discussed in
Section 3.2.1)
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